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It is well established that self-peptide Major Histocompatibility Complexes (hereafter self-
pMHC) are essential for the development of a broad repertoire of mature, self-tolerant CD4 and 
CD8 T cells.  Despite clear knowledge that the pool of self-ligands is critical for positive and 
negative selection, the exact kinetics and dynamic nature of thymocyte interaction with self-
pMHC class II (self-pMHCII) bearing antigen-presenting cells (APCs) during development is 
still largely a mystery. The enigmatic nature of selecting self-pMHC is not unique to the thymic 
environment; increasingly evident is the dependence of peripheral T cells on extra-thymic self-
pMHC expression, specifically selecting self-pMHC, for their homeostatic maintenance and 
peripheral functionalities. Unequivocal resolution as to the exact nature of selecting self-pMHC 
engagement with thymocytes and mature peripheral T cells has been hindered by the lack of 
known TCR:self-pMHC pairs. Our laboratory has identified the first bona fide, naturally 
occurring self-pMHCII, which positively selects a known CD4 transgenic (tg) T cell. The 
gp250/I-Ek ligand is able to positively select the ANDtg CD4 T cell, which recognizes the 
 x 
agonist ligand MCC/I-Ek.  Using this system, we have surveyed and quantified the endogenous 
presentation of a naturally occurring positive selecting ligand-MHCII complex in the thymus and 
periphery. The redundant presentation of gp250/I-Ek on positive selecting cortical epithelial cells 
as well as tolerance inducing APCs lends credence to an affinity model of thymic selection, 
dependent upon re-recognition of “public” self-pMHC complexes in the thymus. The peripheral 
expression of this public ligand is affected by the activation state of peripheral APCs, suggesting 
that the recent immune status can impact the homeostasis of T cell repertoires unrelated to the 
ongoing immune response. Importantly, the expression of functional self-pMHCII complex does 
not correlate with mRNA levels, indicating a need to functionally detect the presence of these 
important ligands in order to gain a complete understanding of how they orchestrate the critical 
processes of T cell development and peripheral maintenance.  
 
In an ongoing attempt to more completely understand the early events and cellular interactions 
critical to thymic selection, we have developed a novel method of in situ, intravital, two-photon 
imaging of the murine thymus. This groundbreaking technique allows for the visualization of 
thymic selection events that occur with intact vasculature and innervation, providing an 
advantage over current explantation methods to view intrathymic events. Indeed, published data 
in regards to the post-positive selection motility of thymocytes in explant preparations appear to 
overestimate the intrathymic cellular dynamics when compared to intravital imaging. Not only 
can utilization if the intravital imaging technique give a complete view of ongoing selection 
events, it is currently the only method to visualize the earliest thymic seeding events. Within 15 
minutes of intravenous administration, fluorescently labeled bone marrow cells can be viewed 
within the thymic vasculature. Over the time of imaging, bone marrow cells can be viewed at 
 xi 
each stage of extravasation into the thymic tissue. The ability to visualize the earliest thymic 
seeding events will provide a novel method to address longstanding questions in the field of T 
cell selection. 
 
A T cell’s dependence on recognition of self-pMHC does not end in the thymus; mature 
peripheral cells continue to require self-pMHC signals for survival. The exact nature of this 
interaction continues to be a topic of active research. Curiously, it appears that the same ligands 
experienced during thymic selection play a unique role in naive T cell homeostasis. Investigation 
of gp250/I-Ek mediated homeostatic maintenance of ANDtg CD4 T cells suggests that this 
confirmed endogenous selecting ligand can augment homeostatic proliferation. How this weak 
TCR engagement mediates homeostatic responses is unknown. Hypothesizing that the strength 
of self-reactivity dictates the degree of homeostatic proliferation, we turned to a different TCRtg 
system, LLO. We observed that despite only a few amino acid differences in their TCR and 
equivalent affinity for the same agonist pMHCII, the LLO118 CD4 T cell underwent reduced 
homeostatic proliferation compared to the LLO56 counterpart. The main difference between 
these two TCR is the strength of self-reactivity; LLO118 is less self-reactive as indicated by CD5 
expression, suggesting that self-reactivity is correlated with homeostatic capacity. 
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CHAPTER I 
 
Introduction: Self-pMHC in the development and function of mature T cells 
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Some of the figures presented here represent the data of Wan-Lin Lo and Scott Weber, 
former graduate student and postdoctoral fellow in our laboratory, respectively. They are 
credited for their contributions as indicated in each figure legend. That work has been 
published as articles in Nature Immunology 20091 and PNAS 20122.  
 
 
Every organism faces the challenge of protecting itself from external and internal assaults. 
Commonalities exist within the entire animal kingdom, however among higher vertebrate species 
evolution of an adaptive immune response provides the capacity to remember exposure to 
pathogens and better prepare for future responses. Unlike the non-specific protection afforded by 
the innate immune system, adaptive immunity offers unique protection against specific 
pathogens and protects from re-infection, thus the basis of vaccination. All components of 
adaptive immunity, including: the myriad T cell subsets, antigen-presenting cells (APCs), B cells 
and antibodies, and primary and secondary lymphoid organs, work in concert to accomplish this 
protection. In regard to the T cell arm of adaptive immunity, protective capacity is established 
early in life, and the complicated process of T cell development produces a repertoire of T cells 
that will protect against infection for the entirety of life. At a cellular level, this is widely the 
result of the combinatorial diversity exhibited by T lymphocyte antigen receptors and the 
subsequent selection of effective mature T cells. This chapter will specifically discuss the 
important steps of T cell receptor generation and T cell quality control via thymic selection, as 
well as the critical nature in which intrathymic development shapes mature, peripheral T cell 
repertoire stability and function. 
 
T cell development is initiated upon progenitor entry into the thymus 
T cells, so named because of their development in the thymus, undergo a complex maturation 
process before establishing their effector capacities. This begins with the entry of bone marrow 
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resident progenitor cells into the thymus3. Because the thymus does not contain self-renewing T 
cell progenitors (TCPs) these cells must be imported from the bone marrow through the blood. 
Unknown thymic niche factors control the volume of TCP entry independent of the number of 
TCP available in the blood4. Interestingly, the thymus appears to undergo periods of receptivity 
to TCP entry, and the mechanisms of this gate-keeping are currently under investigation in the 
field5. It is clear that the entry of TCPs requires a multi-step adhesion cascade utilizing 
expression gradients of molecules such as P-selectin and the chemokine CCL256. More recent 
work suggests that the observed waves of TCP entry may be correlated to the temporal 
regulations of these, and other, adhesive and attractant molecules7. Regardless the hitherto 
unknown mechanisms of TCP entry, upon gaining access to the thymic microenvironment TCPs 
undergo an intricate maturation process on the way to becoming mature, self-tolerant T cells. 
This developmental process is closely linked to the 3-dimensional architecture and unique 
stromal environments comprising the thymus. The development of a lifelong T cell pool occurs 
early in life, and the thymic atrophy that accompanies aging is closely linked to a reduction in 
thymic output over time8. An unanswered question in T cell adaptive immunity is how the 
thymus shape a T cell repertoire that so effectively predicts what TCR will be needed for lifelong 
protection. 
 
Thymic architecture and unique cellular composition orchestrate T cell selection 
The thymic microenvironment is an essential factor in the development of a mature T cell 
repertoire. As indicated above, cues from this environment are essential for the initial 
recruitment of T cell progenitors (TCPs). From here, the dependence grows. Before a thymocyte 
rearranges its antigen receptor or depends on self-peptide MHC (self-pMHC) signals for 
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survival, the thymic stroma provides an uncommitted TCP the Notch ligands required for T cell 
lineage commitment9, 10. Reciprocal bone marrow (BM) transfers between nude and SCID mice 
were used to determine that the thymic stroma was crucial for thymocyte development. Nude 
mice have a defect in epithelial development while SCID mice have TCR rearrangement defects; 
both are T cell deficient. TCPs from nude mice develop normally in SCID BM recipients, which 
possess functional thymic environments. However, SCID TCPs cannot develop into mature T 
cells regardless which thymic environment due to intrinsic defects11. It is clear that there is a 
necessary interplay between thymocytes and epithelial cells, each depending on the other for 
fully efficient development and survival12, 13.  
 
The stages of intrathymic selection are largely segregated into distinct anatomical locations 
within the thymus. The TCPs enter at the cortical-medullary junction through blood vessels and 
undergo a concerted journey throughout the thymus. The self-pMHC independent stages of 
thymocyte development first occur in the outer subcapsulary region of the thymus, and 
subsequently move toward the medulla after surviving the 3-4 day gauntlet of self-pMHC 
mediated positive selection. Positive selection occurs in the cortex among cortical thymic 
epithelial cells (cTECs) and very few bone marrow derived APCs, and will be discussed in 
complete detail later in this chapter. This migratory pattern is thought to depend on the specific 
chemokines produced by the stromal cells in each location. Tolerance inducing negative 
selection occurs primarily in the medulla among thymic DCs and medullary thymic epithelial 
cells (mTECs)14, 15, 16. The cortical and medullary regions of the thymus can be distinguished 
based on the tight packing of bone marrow derived DCs and macrophages in the medulla and 
their absence in the cortex. Furthermore, mTECs are morphologically distinct from their positive 
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selecting cTEC counterparts, and exhibit broad and sheet-like morphology as opposed to the thin 
reticular shape of the cTECs17. Due to the dynamic cellular interaction occurring during thymic 
selection, these morphological distinctions may contribute to the unique functions of the cortical 
and medullary TECs. The unique steps of thymocyte selection and the critical role of self-peptide 
expression within the unique thymic environments will be further discussed. 
 
Two-Photon microscopy and the study of thymocyte selection 
The intrathymic dynamics of T cell development have been of interest for some time. 
Specifically, the precise kinetics and dynamics of thymocytes during a bona fide positive 
selection event in vivo is unknown. Using state of the art two-photon imaging techniques, 
investigators have begun to visualize the interaction of thymocytes undergoing intrathymic 
selection in various in vitro and in vivo systems18, 19.  It is still unclear from these systems if 
positive selection requires a few, long duration contacts with selecting self-pMHC expressing 
cTECs or many short-lived interactions; some studies indicate that both types of interactions 
occur in a positive selecting environment followed by directed migration toward the medulla19, 
20. Elucidating the cellular dynamics of thymocyte:thymic APC interaction during negative 
selection is likewise of interest. Thymocytes that enter the medulla after positive selection are 
thought to have a fast motility rate that allows them to make multiple and transient contacts with 
medullary DCs and mTECs; negatively selected thymocytes are then thought to slow their 
motility and remain in a confined zone, engaging with medullary APCs for longer periods of 
time before being quickly engulfed by medullary macrophages after dying21. The frequent and 
abundant contact of thymocytes with medullary APCs may be key for central tolerance, allowing 
thymocytes to interact extensively with the thymic environment in search of self-pMHC signals. 
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As no in vitro system fully replicates in vivo T cell development, it is necessary to develop in 
vivo systems for investigation. Unequivocal determination of the kinetics and cellular dynamics 
involved in positive selection have been hindered by the available systems, of which CD8 
selection models predominant, and in which the study of CD4 T cell selection has been limited to 
MHC deficient environments and artificial TCR:selecting ligand pairs20, 21. As more confirmed 
endogenous selecting ligand:TCR pairs, such as the CD4 ANDtg:gp250/I-Ek positive selection 
system1, are identified,  visual evaluation of bona fide selection events will be tremendously 
informative.  
 
Advances in microscopic techniques allowing for increased time and depth of imaging have lead 
to optimism in regards to being able to visualize a selection event unfold. However, to date, 
visualization of thymocyte selection has required the ectopic growth of thymic rudiments, or 
explantation and slicing of whole thymi17, 18. Visualization of T cell development in situ would 
be a significant advance. Using current techniques, the initial events of thymic seeding can be 
investigated using fluorescent imaging because they are intimately linked to the thymic 
vasculature. Given the known complexities of thymocyte selection and the plethora of cues 
required for development, it is not unlikely that removing the thymus from its native 
environment has wide spread effects related to changed in innervation and chemical signals22, 23. 
The work herein describes a novel technique for the in vivo imaging of the mouse thymus. 
Careful surgical procedures are used to image the thymus with intact vasculature and innervation 
while reducing the movement cause by cardiac and respiratory functions. 
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The self-pMHC independent stages of thymocyte development 
Upon entering the thymus, thymocytes express neither the CD4 nor CD8 coreceptor, and are 
termed double negative (DN). DN thymocytes migrate from the cortico-medullary junction 
toward the outer subcapsulary region within the cortex of the thymus. Throughout the DN stages, 
thymocytes undergo RAG (recombination activating gene) mediated V(D)J recombination in 
attempts to generate a functional TCRβ chain. At the final DN4 stage, the β chain pairs with the 
invariant preTα chain and the cell commits to the αβ lineage24, 25. Nonhomologous V(D)J 
recombination generates billions of diverse TCR sequences throughout the random joining of 
TCR gene segments. Further random modification adds variability centered at the CDR3 region 
that contacts pMHC. Elegant studies early on showed that MHC restriction was imprinted in the 
thymus26. While the large pool of unselected thymocytes develops independently of self-pMHC 
recognition, the final TCR repertoire is only about 5% of this starting population. The quality 
control mechanisms that pare down this initial TCR pool are referred to as positive and negative 
selection, and depend on the landscape of self-pMHC presented within the thymus27, 28.  
 
The self-pMHC dependent stages of thymocyte development: positive and negative selection 
After the self-pMHC independent generation of a TCR β:pTα pair, thymocytes begin their 
lifelong dependence on self-pMHC. During the transition from CD4- CD8- DN to CD4+ CD8+ 
double positive (DP) thymocyte, developing T cells rearrange their TCR β and α loci until a 
functional receptor is identified via interaction with self-pMHC. Crosslinking of the TCR by 
self-pMHC recognition results in the inactivation of RAG and subsequent termination of further 
α chain rearrangement, a phenomenon known as allelic exclusion29, 30. Allelic exclusion of the 
TCR α chain is an incomplete process, and as such there do exist mature T cells that posses two 
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functional TCRα chains. There is a distinct possibility that these “dual alpha” T cells can 
uniquely contribute to alloreactivity31 and autoimmunity32 by allowing for the maturation of a 
TCR that evades the rigors of thymic selection via piggybacking on a properly selected TCR on 
the same cell33. DN thymocytes that appropriately crosslink their TCR pass the first stage of 
selection and graduate to become CD4 CD8 DP thymocytes and undergo the gauntlet of positive 
and negative selection. 
 
Positive and negative selection 
The TCR diversity generated through V(D)J recombination is dramatically reduced through the 
processes of positive and negative selection. These processes ensure that the mature T cell pool 
is comprised of members that recognize pathogens with exquisite specificity while avoiding self-
reactivity, and both depend on the interaction of newly generated TCR with self-pMHC 
molecules34, 35, 36. The exact mechanisms as to how a thymocyte can require constant self-pMHC 
engagement for survival (positive selection) yet undergo apoptosis mediated death as a 
consequence of the same interaction (negative selection) has been a topic of active investigation 
for some time. A variety of non-mutually exclusive models have been proposed to address this 
paradox and, despite the differences, tend to hinge on the affinity of the interaction between TCR 
and self-pMHC37. Without the proper engagement with self-pMHC ligands, DP thymocytes die 
due to neglect, however if the interaction affinity is too great, the DP thymocytes die of negative 
selection.  
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Positive selection requires the weak interaction of DP thymocytes with self-pMHC on cTECs, 
while negative selection of thymocytes with strong reactivity for self-pMHC is thought to occur 
primarily on mTECs and medullary thymic DCs34, 35, 38 
. Many studies, using CD8 systems or detuned agonist peptides, have shown that the selecting 
self-pMHC repertoire for a given T cell is rare and of a weak affinity; interactions of positive 
selecting ligands with TCR are often unable to be measured by standard 3D biophysical and 
tetramer decay methods39, and do not stimulate mature T cells. Our identification of only 1 out of 
95 I-Ek binding peptides with the ability to positively select an I-Ek restricted transgenic T cell 
further indicates the relatively rare nature of selecting ligands1. It is further suggested that 
positive selecting and tolerance inducing thymic APCs may display some set of private, non-
overlapping peptides that provide additional tests for developing thymocytes40. The mechanisms 
by which cTECs and negative selecting thymic APCs may present unique self-pMHC, and the 
impact of this difference on the mature T cell repertoire, will be discussed.  
 
Regardless of the derivation of the selecting self-pMHC, the cascade of intracellular events 
initiated by the TCR:self-pMHC interaction either lead to survival and CD4 or CD8 lineage 
commitment, or death. Specifically, negative selection is accompanied by a transient and intense 
burst of ERK activation and calcium influx, but the survival of positively selected cells depends 
on the sustained maintenance of these signals36, 41, 42. Like positive and negative selection, the 
decision to become a CD4 or CD8 single positive (SP) T cell is also thought to depend on the 
strength of recognition through the TCR, in addition to signals provided via the CD4 and CD8 
coreceptors. Within the permissive range for positive selection, it is thought the highest affinity 
TCRs develop into natural regulatory T cells or innate-like T cells, while those within the mid 
 10 
range of the selection affinity window become CD4 and the lower end CD8 SP cells43, 44. The 
strength of interaction, along with the choreographed display of coreceptor during positive 
selection, results in a temporal discrepancy between CD4 and CD8 SP thymocyte development. 
No matter the final fate, DP thymocytes initially down-regulate their CD8 coreceptor. Should the 
thymocyte be selected on a class II self-pMHC, the strong and sustained signal leads to the rapid 
establishment of CD4 SP cells. However, if the DP thymocyte is receiving class I mediated self-
pMHC signals, it must undergo the process of coreceptor reversal in which CD8 is re-expressed. 
As such, CD8 SP cells require an increased development time of up to four days45, 46.  
 
In addition to the expression, or lack of expression for DN thymocytes, of coreceptors, there are 
a variety of other surface markers that allow for the identification of discrete stages in thymocyte 
development. While DN thymocytes are distinguished based on CD44 and CD25 expression, DP 
thymocytes undergoing positive selection also exhibit characteristic surface phenotypes. Pre 
selection DP thymocytes express low levels of CD5, CD69 and TCRβ.  Studies indicate that 
CD69 is an early marker of positive selection, and increases on post-positive selection DP and 
SP cells, but is not expressed pre-selection DP or DN cells. Positive selection by self-pMHC is 
also accompanied by increases in CD5 and TCRβ levels28, 47. The timing and subset specific 
expression of these markers have been utilized herein for the experimental investigation of the 
role self-pMHC play throughout the life of a CD4 T cell. Specifically, the CD69 expression 
pattern will be utilized as tool for visualizing positively selected cells within this dissertation. 
CD5, another marker of positive selection, is also an option for identification of positively 
selected thymocytes, however its functional role in T cell biology is not firmly established and its 
usefulness as a marker of weak TCR:self-pMHC engagement is discussed below48. Some think 
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that within the affinity threshold of positive selection, CD5 expression levels may dictate a T 
cell’s peripheral functionality2, 49, which is an attractive hypothesis given the tremendous 
consequences of thymic selection on the mature T cell functionality and repertoire50. It not 
entirely evident what biological impact positive selection has on the mature T cell, and some 
believe that thymic selection may enrich for TCR that better recognize foreign antigens51. 
Indeed, work from our laboratory confirms the intimate relationship between a thymocyte’s 
reactivity to self-pMHC in the thymus and its effector capacities as a mature T cell, though 
perhaps not in a simply correlative manner52. 
 
The early discoveries of MHC self-restriction and of TCR binding peptide loaded MHC 
complexes illuminated many key elements of immune recognition, but did not clarify how self-
tolerance was established53, 54. Along with other laboratories, our laboratory provided some of 
the first clues that self-tolerance developed in the thymus. Using the Hb/I-Ek system, endogenous 
self-pMHC were identified on both peripheral and thymic APCs, suggesting that thymus might 
be the location of self-tolerance induction55. It is now known that the immunological sense of 
self is defined in the thymus via positive selection and enforced via negative selection51. The 
elimination of strongly self-reactive thymocytes before they escape into the periphery is one key 
component of self-tolerance and autoimmunity prevention. Though this primarily occurs in the 
distinct medullary region of the thymus, should a thymocyte interact too strongly with self-
pMHC at any thymic location, it can be deleted. The molecular mechanisms that allow the same 
TCR to signal dramatically different cell fates, positive selection induced proliferation or 
negative selection induced apoptosis, in response to slightly different ligand affinities is an 
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ongoing area of investigation, and may depend on nonexclusive mechanisms involving changes 
in TCR and CD5, voltage-gated sodium channels and intracellular signaling molecules27, 56. 
 
Establishing the self-pMHC landscape 
The expression of self-pMHC expressing APCs is not uniform within the thymus, and it is clear 
that the cortical or medullary location of a self-antigen will impact the developmental stage at 
which the thymocyte experiences the self-pMHC; note that DP cells can be negatively selected in 
the cortex if the TCR engagement is of sufficient affinity. One mechanism for the differential 
expression of self-pMHC throughout the thymus is the utilization of distinct processing 
machinery. As in the periphery, housekeeping and immunoproteasomes are both available for the 
generation of pMHCI complexes; the immunoproteasome is specifically expressed in mTECs 
and medullary thymic DCs and is independent of IFNγ stimulation. cTECs constitutively express 
a version of the housekeeping proteasome called the thymoproteasome containing the β5t 
subunit, and generate their own diverse self-peptide repertoire. Using different proteasomal 
processing ensures that cTECs can display disparate self-pMHCI from mTECs and DCs57. 
Further processing differences are evident within the MHCII system as well. cTECs utilize 
thymus-specific-serine-protease (TSSP) and Cathepsin L, specifically, for degradation of 
proteins in the endosomal and lysosomal compartments, while mTECs and DCs utilize Cathepsin 
S, thus generating distinct peptide pools for MHCII expression58. These mechanisms allow 
thymic APCs to present both unique, private self-pMHC ligands, as well as overlapping, public, 
ligands. Overall, the differences between cortical and medullary thymic APCs’ processing 
pathways illuminate a selection system in which the negatively selecting components most close 
resemble peripheral APCs.  
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In addition to the antigen processing differences between the cortex and medulla, there are also 
important genetic differences. Though cTECs and mTECs are derived from a common Foxn1 
dependent precursor59, unique gene expression further allows for the differential expression of 
self-pMHC that likely dictates intrathymic selection. mTECs are particularly notorious for 
promiscuous gene expression; this trait is dependent on expression of AIRE, and the 
transcriptional mechanisms by which AIRE promotes the ectopic expression of tissue restricted 
antigens is being investigated. Though previous investigations as to the thymic APCs sufficient 
for negative selection highlighted the importance of DCs over mTECs38, recent studies have 
confirmed the ability of mTECs to not only express tissue restricted antigens, but present them to 
thymocytes and induce negative selection60. Prior to these studies, it had been thought that 
mTECs simply provide a reservoir of self-antigen for medullary DCs through cross presentation 
mechanisms. It is clear that DC play a critical role in central tolerance, and that they retrieve 
their self-pMHC cargo through a variety of mechanisms, including cross-presentation of mTEC 
antigens and direct membrane transfer; immigrated DCs are also known to present peripherally 
and blood derived self-antigens within the medulla61, 62. The differential self-pMHC expression 
among thymic APCs is an interesting phenomenon addressed herein. A complete understanding 
of the self-pMHC ligandome is essential for understanding how the mature T cell repertoire is 
shaped. Critically, these peptides inform the generation of T cells that anticipate all future 
pathogenic exposures at the beginning of life. 
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Subthreshold ligands: the effect of weak TCR engagement with self-pMHC 
Self-pMHC are critical ligands in the life of a T cell. The interactions between the TCR of naive 
cells and self-pMHC, like that between thymocyte TCR and self-pMHC, are weak and do not 
typically activate the T cells. Though the T cell is not activated, this signal is registered through 
the TCR, as indicated by partial tyrosine phosphorylation of the TCRζ chain which is often used 
as an indication of weak TCR engagement63. Various effects have been proposed to result from 
TCR interaction with weak ligands. During positive selection, these weak interactions provide 
the essential stimuli for selection and the subsequent survival, proliferation and maturation of DP 
thymocytes. Careful investigation showed that despite lower levels of TCR expression, pre-
selection thymocytes are more sensitive to signals through the TCR than their mature 
counterparts64. Our lab has recently shown that this increased sensitivity can be attributed, in 
part, to expression of specific voltage-gated sodium channels that allows for sustained calcium 
flux in response to weak interaction with positively selecting ligands39. Interestingly, the 
decreased sensitivity of mature T cells compared to DP thymocytes does not preclude the 
peripheral engagement of mature TCR with selecting self-pMHC.  
 
The effects of peripheral recognition of self-pMHC by T cells is a topic of much debate, with 
data suggesting roles for self-pMHC in naive cell homeostasis, as discussed below, increased 
recognition of foreign antigens, and the peripheral prevention of autoimmunity. Some studies 
also point to a role for selecting self-pMHC in coagonism1, 39, 65, perhaps through sustaining the 
TCR sensitivity to foreign pMHC through partial tyrosine phosphorylation of TCRζ and 
polarization of TCR signaling components. Others suggest that TCRs that bind well to weak 
ligands in the thymus are simply poised for increased recognition of foreign antigens in the 
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periphery66. Work from our laboratory does not confirm this finding. In the LLO TCRtg system, 
which is utilized herein and described in detail below, the CD5High LLO56 CD4 T cell recognizes 
self-pMHC with a higher affinity than LLO118, as indicated by CD5 expression levels. A key 
component of this system is both TCR recognize foreign antigen with the same affinity.  
However, LLO118 excelled in terms of expansion during the primary response to Listeria 
monocytogenes2. The discrepancy in finding from different groups suggest that more work is 
required to unequivocally determine the exact mechanisms by which thymic self-recognition 
informs that peripheral immune response. Additionally, separate work using syngeneic skin 
grafts in the presence or absence of self-pMHC indicate that self-pMHC recognition is necessary 
for the efficient prevention of autoreactivity67. 
 
The recognition of weak TCR ligands is thus a critical area of investigation, with important 
questions remaining as to how the sensitive thymocyte reactivity allowing positive selection can 
be modulated to prevent autoreactivity among mature T cells using the same TCR. One molecule 
of interest is CD5. Aside from its role as a marker for self-reactivity, it is thought to be a 
negative regulator of TCR signaling68. TCR with recognition on the high end of the positive 
selection spectrum seem to be associated with higher CD5 levels both within the thymus and the 
periphery, which some speculate detunes the TCR as a preventative measure against reactivity to 
self-antigens37, 68, 69, 70. Though CD5 KO mice do not exhibit defects in polyclonal T cell 
development, many key pieces of data using transgenic systems indicate that the CD5 molecule 
may be an important component of intrathymic selection71. The exact biological functions of this 
molecule remain enigmatic.  
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Measuring the affinity of TCR for self-pMHC has proven difficult due to the weak nature of the 
interaction. Though new technology in the field of 2D kinetic measurements are improving our 
ability to approximate low affinities72, the studies of TCR engagement with weak pMHC have 
relied on assumptions of affinities based on correlative marker expression and TCR 
phosphorylation. Furthermore, lack of known, bona fide selecting self-pMHC ligands has forced 
the use of detuned agonist and antagonist ligands (altered peptide ligands, APLs) to investigate 
models of self-peptide recognition. The rare nature of cTECs which positively select thymocytes 
and the weak affinity of self-pMHC for TCR have made identification of endogenous selecting 
ligands particularly difficult 40. Though these altered peptide ligands provide an indication of the 
TCR affinity spectrum and the functional consequences of these affinities, the few known 
positively selecting ligands often do not resemble their agonist counterparts and as such, peptide 
mimics may not be the best tool for investigating weak TCR:self-pMHC interactions. Having 
identified the first naturally occurring CD4 T cell positive selection system, AND:gp250/I-Ek, 
our laboratory can contribute to the understanding of the mechanisms at play when a bona fide 
positively selecting ligand interacts with its TCR. This transgenic system and our use of it to 
investigate the self-pMHC landscape are described below. 
 
Self-pMHC are required in secondary lymphoid organs 
Numerous studies have contributed to the current understanding of the intricate mechanisms of 
positive and negative selection, the intrathymic processes that shape the development of a mature 
T cell repertoire that is both MHC restricted and self-tolerant. Both of these processes are 
intimately dependent on the recognition of self-peptide MHC (self-pMHC), and the diversity of 
self-pMHC available during intrathymic selection dramatically impacts the mature T cell 
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repertoire27, 73. Though it is obvious why the deletion of self-reactive thymocytes during negative 
selection should rely on the recognition of self-peptide presenting MHC molecules, it is less 
clear why signals from self-pMHC are required for the survival of DP thymocytes during 
positive selection, especially considering that MHC-restriction, which occurs during positive 
selection, appears to depend on germline encoded affinity of TCR for MHC36, 74. In the late 
1990’s, it became clear that some amount of naive T cell homeostasis in the periphery was 
dependent on self-pMHC, specifically the selecting self-pMHC75, 76, indicating a potential link 
between the self-pMHC mediating positive selection and those found in the periphery. 
 
Mature T cells that have escaped the gauntlet of intrathymic selection still have to compete for 
survival factors when they enter the periphery. Once selected, they require a constant supply of 
homeostatic factors to ensure their survival and functionality. Though the thymus produces fewer 
T cells with age, the peripheral number of T cells remains relatively constant during and after T 
cell emigration from the thymus. Additionally, the number and diversity of the T cell pool must 
remain constant after the contraction phase of an immune response, indicating the existence of 
critical homeostatic mechanisms in the peripheral environment. These include cytokine, 
specifically IL-7, and self-pMHC:TCR signaling77, 78.  
 
Over the course of multiple studies, it has become increasingly evident that self-pMHC provide 
support for naive T cells to survive in the absence of antigenic stimuli, and proliferate under 
lymphopenic conditions76, 77, 79. Further studies indicate a requirement for the peripheral self-
pMHC repertoire to reflect the selecting self-pMHC specifically; naive CD4 T cells that develop 
in a normal T cell environment do not proliferate or transition into CD44High memory phenotype 
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cells when transferred into a pMHCII restricted H2DM-/- host. However, if the naive CD4 cells 
first develop in an H-2DM-/- environment, they proliferate and convert as is expected when 
transferred into an H-2DM-/- host. Though many investigators have come to this same 
conclusion, others contend that, though naive CD4 T cells do engage selecting self-pMHCII in 
the periphery, this interaction is not required for their maintenance63, or that is responsible for 
dampening the naive T cell response to autoantigens67 and not homeostasis. Much of the 
controversy stems from differences in the transfer systems used to study T cell homeostasis; 
lymphopenic conditions create space that allows naive T cells to proliferate and transition into 
memory phenotype cells when they would otherwise remain mostly quiescent in a lymphoreplete 
environment80, 81. It is argued that the confounding factor of lymphopenia prohibits the 
investigation of naive cell maintenance in steady sate conditions. 
 
Additionally, there are differences in the forms of lymphopenia. Chronically lymphopenic (Rag-/-
or SCID) mice are constitutively presenting peptides from nonpathogenic commensal bacteria. 
However mice that are rendered lymphopenic acutely (sublethal irradiation) have MHC that are 
predominately loaded with endogenous self derived antigens79. Though “self” antigens derived 
from endogenous or commensal sources are both able to induce homeostatic proliferation82, 
acutely lymphopenic conditions are thought to better illuminate the roles of endogenous selecting 
self-pMHC in naive T cell homeostasis, which is the topic of investigation in the aims below. 
Not only does the source of self-pMHC impact the peripheral maintenance of naive T cells, some 
studies indicate that the affinity of the TCR, dictated in the thymus, intimately regulates a T 
cell’s homeostatic ability. Not all TCRtg cell lines undergo lymphopenia induced proliferation, 
and some studies indicate that high affinity interaction with self-pMHC, as indicated by high 
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CD5 expression levels, is required for peripheral T cell maintenance and functionality66, 83, 
however this has yet to be unequivocally confirmed. Interestingly, ANDtg T cells from the H-
2Kb background, have high CD5 expression levels but are not thought to undergo homeostatic 
proliferation upon transfer into lymphopenic hosts, indicating a need to more closely evaluate the 
link between CD5, TCR:self-pMHC affinity and peripheral T cell maintenance. Work in this 
vein is described herein. 
 
ANDtg:gp250/I-Ek: A bona fide, naturally occurring CD4 positive selection system 
Our lab has recently identified the ANDtg CD4 T cell to be positively selected by gp250/I-Ek 1. 
Investigation as to the exact nature CD4 selecting self-pMHC has lagged behind similar studies 
among CD8 T cells due to the inability to identify a naturally occurring selecting self-pMHCII84, 
85.  To this end, previous researchers in our laboratory generated a panel of 95 peptides that 
naturally bind I-Ek on the CH27 B cell line86 and they were loaded onto I-Ek Ig dimers. DP 
thymocytes from four separate I-Ek reactive CD4tg lines, bred onto non-selecting MHC 
background to ensure the absence of CD4 SP post selection thymocytes, we analyzed for CD69 
upregulation against the self-peptide I-Ek panel. Of the 380 potential TCR:self-pMHCII pairs, 
only one showed CD69 upregulation, AND:gp250/I-Ek (Figure 1.1). This is in accordance with 
early data suggesting that ligands able to select a given TCR are quite rare among the entire self-
pMHC population87, 88. In reaggregate cultures with the ANV/I-Ek cTEC cell line (a cell line that 
expresses very few self-pMHC) pulsed with gp250, ANDtg DP thymocytes became CD4 SP 
thymocytes and upregulated standard markers of positive selection: CD5, CD69 and TCRβ 
(Figure 1.2). In further confirmation of the extreme specificity of a TCR for its selecting self-
pMHC, altered peptide ligands (APLs) of gp250 at the predicted TCR contact residues were 
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unable to mediate the positive selection of ANDtg CD4 SP cells in reaggregate culture (Figure 
1.3), despite the fact that these mutations mimicked agonist ligand residues. Of note is the fact 
that gp250 has no sequence homology to ANDtg CD4 T cells’ agonist peptide moth cytochrome 
C (MCC)1, 89. That this bona fide positive selecting ligand does not structurally mimic the agonist 
ligand suggests that the popular hypothesis that mimicry of agonist ligands is a predominate 
purpose of thymic positive selection is likely incomplete. 
 
In addition to identifying gp250 as an endogenous positive selecting ligand and confirming that it 
is bona fide in its ability to generate CD4 SP cells from DP thymocytes, our laboratory further 
elucidated that this selecting ligand likely plays roles in the peripheral maintenance and function 
of mature ANDtg CD4 T cells. Using a novel in vitro assay to modulate the ratio of agonist 
MCC:positive selecting gp250 peptide loaded onto I-Ek dimers, we have shown a potential role 
for gp250 in augmenting ANDtg CD4 T cell responses to agonist ligand, in other words, acting 
as a coagonist (Figure 1.4). Additionally, exogenous addition of gp250 peptide was shown to 
increase the recovery of ANDtg CD4 T cells after adoptive transfer into chronically lymphopenic 
Rag2-/- recipients (Figure 1.5). These data are in line with hypotheses as to the role of self-
pMHC in coagonism and homeostasis. Further establishing the role of selecting ligands and TCR 
self-reactivity in the peripheral maintenance of CD4 T cells is a predominate focus of this 
dissertation.  
 
The gp250 peptide is derived from the sortilin-related LDL endocytic receptor, encoded by the 
LR11 gene. Its transcripts are expressed to various degrees in all known APC subsets 90, 91 
(Figure 1.6). To more completely evaluate the selection of ANDtg CD4 T cells by gp250/I-Ek, 
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as well as the peripheral role of this naturally occurring positive selecting ligand, we obtained the 
gp250KO mice from Hideaki Bujo and Yasushi Saito92. We bred them to the ANDtg B6.K Rag1-
/- mice and initially observed that selection of ANDtg CD4 cells was severely diminished in the 
absence of gp250, with reduced numbers of mature ANDtg CD4 cells making it into the 
periphery (Figure 1.7). Other than defects in the development of ANDtg CD4 T cells, the 
gp250KO mice are immunologically normal. Using this system, our laboratory is uniquely suited 
to investigate longstanding questions in regards to the endogenous landscape of a confirmed 
positive selecting self-pMHC, in addition to the intricate relationship between an effective, 
predictive T cell repertoire and the ligands that select it.  
 
LLO TCRtg system: investigating thymocyte self-reactivity and peripheral T cell function  
As discussed, CD5 expression levels represent the strength of TCR self-reactivity, and this 
interaction is thought to critically inform the thymic development and peripheral functions T 
cells40, 48, 67. Our laboratory has generated multiple TCRtg pairs that recognize the same cognate 
antigen, but exhibit disparate avidities for self-peptide as measured by CD5 expression. Herein, 
we utilize the LLO TCRtg system to further investigate how the strength of positive selection 
and self-peptide recognition impact the homeostatic maintenance of mature, peripheral CD4 T 
cells. Initially created by Scott Weber, a former postdoctoral fellow in the laboratory, the LLO56 
and LLO118 TCRtg CD4 T cells recognize the same immunodominant epitope listeriolysin O 
(190-205) from Listeria monocytogenes (LLO190-205/I-Ab)2. These TCRs were chosen from 
LLO190-205-specific T cell hybridomas having identical Vα and Vβ variable gene usage, namely 
Vα2 and Vβ2. They differ in only 15 amino acids, primarily located in the CDR3 regions. 
Furthermore, the only discernable difference in surface marker expression was that of CD5 
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(Figure 1.8). LLO56 exhibits higher CD5 levels than its LLO118 counterpart. Given these 
findings, we have generated TCRtg CD4 T cells that recognize the same agonist ligand, but 
presumable have differing affinity for self-pMHCII. 
 
In keeping with the theory that the self-reactivity of a T cell impacts its peripheral function, our 
laboratory observed a discrepancy in the primary response of the LLO TCRtg CD4 T cells to 
primary Listeria infection. Contrary to correlative studies suggesting that higher self-reactivity 
begets increased response to foreign antigen66, we observed that the CD5High LLO56 cells 
responded less well to Listeria infection compared to LLO118 in terms of the proliferative 
response in the primary response. This discrepancy was reversed in the recall response, with 
LLO56 predominating (Figure 1.9). The mechanisms and details of this interesting phenomenon 
are the work of a previous graduate student in the laboratory52. Herein, we investigate a potential 
role for the difference in self-reactivity in the homeostatic maintenance of these LLO TCRtg 
CD4 T cells. 
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Figure 1.1. The screening for positive selecting ligands. A panel of 95 unique endogenous I-Ek 
self-peptides previously identified from a CH27 B cell line29 were individually loaded onto I-Ek-
immunoglobulin (I-Ek-Ig) dimers, and immobilized on plates along with anti-CD28. Thymocytes 
from four TCR transgenic mice (AND.Rag1–/– H-2d, N3L2.Rag1–/–H-2b, 2.102.Rag1–/–H-2b and 
A1.Rag1–/–H-2b) were incubated overnight in plate and then analyzed by flow cytometry. The 
initial screens utilized crude peptides (> 80% pure), and those inducing CD69 expression on 
greater than 1% of thymocytes were regarded as candidate peptides. Those potential candidates 
identified in the initial screenings were further confirmation with HPLC purified peptides (> 
99% pure). Those candidate peptides shown in grey were not confirmed by HPLC-purified 
peptides, and thus were considered negative. The candidate peptide shown in red was confirmed 
by HPLC-purified peptide in multiple syntheses. Data are representative of two independent 
experiments for each TCR transgenic mouse strain.  Lo et al. 2009, Nature Immunology. 
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Figure 1.1. The screening for positive selecting ligands. Lo et al. 2009, Nature Immunology. 
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Figure 1.2. Positive selection of AND TCR–transgenic thymocytes selected by gp250 in 
reaggregate cultures are phenotypically mature. (a) Flow cytometry analysis of the 
expression of CD4 and CD8 by DP thymocytes from newborn AND.Rag1−/− H-2d mice, cultured 
for 96 h with the I-Ek-transfected cortical thymic epithelial cell line ANV41.2 (I-Ek), along with 
30 µM gp250 peptide or the control peptide Hb (GKKVITAFNEGLK). Numbers above outlined 
areas indicate percent positive selected CD4SP cells. Data are representative of five independent 
experiments. (b) CD4SP differentiation induced by various doses of gp250 peptide (horizontal 
axis) or 30 µM Hb in cells cultured as described in a. (c) Expression of markers of positive 
selection on CD4SP and DP cells in reaggregate cultures pulsed with 30 µM gp250 or 30 µM Hb 
(control peptide). *P < 0.05 (two-tailed Mann-Whitney test). Data represent three-five 
independent experiments (mean and s.e.m.). Lo et al. 2009, Nature Immunology. 
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Figure 1.2. Positive selection of AND TCR–transgenic thymocytes selected by gp250 in 
reaggregate cultures are phenotypically mature. Lo et al. 2009, Nature Immunology. 
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Figure 1.3. Positive selection by gp250 has a high degree of specificity. (a) Aligned amino 
acid sequences of gp250 and MCC. Residues P2, P3, P5 and P8 are predicted TCR contact 
residues (red, upward arrows). (b) Frequency of CD4 SP positively selected in reaggregate 
culture by Hb (negative control peptide), the peptides with single-residue substitutions reflecting 
agonist residues, or gp250 (30 µM). Results are presented as percent CD4 SP cells among total 
thymocytes. *P < 0.05 (two-tailed Mann-Whitney test). Data represent four independent 
experiments (mean and s.e.m.). Adapted from Lo et al. 2009, Nature Immunology.   
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Figure 1.3. Positive selection by gp250 has a high degree of specificity. Adapted from Lo et 
al. 2009, Nature Immunology.   
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Figure 1.4. The gp250 peptide acts as a coagonist for peripheral ANDtg CD4 T cells. 
Coagonist ability of Hb (control peptide), gp250 (a) or gp250 peptides with single substitutions 
(described in Figure 1.3), tested with I-Ek–Ig heterodimers loaded with various ratios of peptides 
(horizontal axis (a) or 1:100 (b)) and coated onto triplicate wells of 96-well tissue culture plates; 
CD4+ peripheral T cells isolated from AND TCR–transgenic (H-2b) spleen cells were cultured on 
the plates for 3 d and pulsed with [3H]thymidine for the final 18–24 h of culture. Data are 
representative of five (a) or three (b) independent experiments (mean and s.d. of triplicate 
determinations (a) or mean and s.e.m. of triplicate wells (b)). Lo et al. 2009, Nature 
Immunology.   
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Figure 1.4. The gp250 peptide acts as a coagonist for peripheral ANDtg CD4 T cells. Lo et 
al. 2009, Nature Immunology.   
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Figure 1.5. Administration of 0.1mg of gp250 enhances survival of homeostatically 
proliferating ANDtg CD4 T cells. CD4+ peripheral T cells were isolated from 
AND.Rag1-/-H-2k spleen cells, CFSE labeled, and transferred to B6.K.Rag1-/- mice by retro-
orbital injection on day 0. The B6.K.Rag1-/- mice were injected intraperitoneally with 0.1 mg 
gp250 or control peptide (Hb) on days -1 and +1. CD4 and CFSE were analyzed by flow 
cytometry. (a) The representative dot plots and (b) histogram are representative of eight 
individual mice from a total of three separate experiments. (c) The total number of T cells 
recovered from pooled inguinal and auxiliary lymph nodes (mean ± s.e.m.) from three separate 
experiments from mice receiving either control (Hb, n = 4) or gp250 (n = 4) peptide. *P > 0.05 
by two-tailed Mann-Whitney test. Lo et al. 2009, Nature Immunology.   
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Figure 1.5. Administration of 0.1mg of gp250 enhances survival of homeostatically 
proliferating ANDtg CD4 T cells. Lo et al. 2009, Nature Immunology.   
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Figure 1.6. Positive selecting ligand gp250 is derived from an endocytic receptor whose 
transcripts are variably expressed. (a) Illustration (by Wan-Lin Lo) depicting the 
transmembrane protein from which the gp250 peptide is derived. (b) NCBI Geo repository of 
gene expression data shows LR11 expression in various tissues (top) thymic APCs (bottom left) 
splenic DCs (bottom middle) and naive or activated splenic B cells (bottom right). 
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Figure 1.6. Positive selecting ligand gp250 is derived from an endocytic receptor whose 
transcripts are variably expressed.  
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Figure 1.7. ANDtg CD4 T cells are positively selected by gp250/I-Ek in vivo. The 
development of CD4 SP cells in the thymus and their presence in the periphery are severely 
diminished in ANDtg/ gp250-/-/Ragk/k mice (a). Intrathymic injection (courtesy of Wan-Lin Lo) 
of gp250 peptide can restore selection of ANDtg CD4 SP cells while irrelevant Hb peptide does 
not; strong agonist peptide, MCC, results in deletion of ANDtg cells (b).  
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Figure 1.7. ANDtg CD4 T cells are positively selected by gp250/I-Ek in vivo.  
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Figure 1.8. LLO118 and LLO56 differ only in few TCR amino acids and CD5 expression. 
(a) Primary sequence differences in the CDR3α and β as well as CDR2β V-regions of the TCR. 
Not shown are the CDR regions of perfect sequence identity between LLO56 and LLO118 TCR. 
(b) Flow cytometry analysis of common T-cell surface markers. T cells were isolated from the 
spleen and cell surface markers were directly analyzed without any stimulation. Data are 
representative of three independent experiments with at least three mice per group each 
experiment. Adapted from Weber et al. 2012, PNAS 
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Figure 1.8. LLO118 and LLO56 differ only in few TCR amino acids and CD5 expression. 
Adapted from Weber et al. 2012, PNAS 
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Figure 1.9. LLO118 T cells have a better primary response, whereas LLO56 T cells have a 
better secondary response to L. monocytogenes infection. (a) CD4+ T cells from LLO118-
Ly5.1 or LLO56-Thy1.1 mice were purified by negative selection and 3x103 cells were 
transferred to C57BL/6 recipient mice. The mice were subsequently infected with 1x104 CFU of 
L. monocytogenes and cell numbers were measured 7 d later by flow cytometery. (b) On day 35 
after the primary infection recipient mice were infected with 1x105 CFU of L. monocytogenes. 
Four days after the secondary infection cell numbers were determined by flow cytometry. Data 
are representative of three independent experiments with at least three mice per group each 
experiment. **P < 0.01 (Student t test). Weber et al. 2012, PNAS 
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Figure 1.9. LLO118 T cells have a better primary response, whereas LLO56 T cells have a 
better secondary response to L. monocytogenes infection. Weber et al. 2012, PNAS 
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CHAPTER II 
 
Self-pMHCII complexes are variably expressed in the thymus and periphery independent of 
mRNA expression but dependent on the activation state of the APCs 
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This chapter has been drawn almost entirely from a manuscript currently in press with 
Molecular Immunology. 
 
Introduction 
The development and maintenance of a functional and self-tolerant T cell repertoire depends on 
the continued interaction between TCR: self-pMHC 36. It is well established that these self-
peptides are constitutively processed and presented 55, 93, 94. Much progress has been made 
toward elucidating the key mechanisms of thymic selection that result in the production of a 
mature T cell pool that not only effectively detects self-peptides presented on MHC molecules 
(positive selection), but also avoids autoreactivity to self-peptides (negative selection). The 
undisputed requirement for recognition of self-pMHC at both the positive selection and self-
tolerizing stages of thymocyte development appears paradoxical, and a variety of non-mutually 
exclusive models have been proposed to explain how the recognition of self-peptides can be both 
essential for survival but also potentially deadly to developing thymocytes 27, 95. Decades of 
investigation have suggested myriad models hypothesizing how this might be. Early work 
suggested that positive selecting cortical thymic epithelial cells (cTECs) display unique peptides 
for positive selection that are not duplicated among APCs involved with tolerance induction in 
the thymus or periphery. However subsequent work showing overlap between cTEC and splenic 
eluted peptide 96, and in vitro assays suggesting the ability of low amounts of agonist ligand or 
antagonist and partial agonist ligands to induce positive selection have led to more current 
models emphasizing the avidity and affinity of TCR: selecting self-pMHC interaction 96, 97, 98. 
 
Currently, intrathymic selection models are evolving with our understanding of the thymic 
microenvironment, and not only account for the affinity of the TCR: selecting self-pMHC 
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interaction, but the quantity, quality, spatial and temporal characteristics of the selecting ligands 
and the APCs that present them 35. Interestingly, a revival of the discrete peptide model is 
ongoing as it becomes clear that the APCs vital for positive selection and central tolerance are 
differentially equipped to process and present unique peptides 91. Though elucidation of the exact 
mechanisms that generate self-pMHC able to mediate thymic selection is ongoing, it is clear they 
are complicated in nature and challenge our current understanding of antigen processing. 
Involvement of antigen processing machinery outside of the “classical” pathways may prove to 
play a vital role in establishing the selecting ligandome that leads to functional and self-tolerant 
CD4 and CD8 T cell repertoires 99. Unequivocal determination of which model, or more likely, 
combination of models, most accurately reflects in vivo thymocyte selection depends intimately 
upon gaining an understanding of the landscape of selecting self-pMHC complex expression. 
Specifically, a clear understanding of if and how the ligand complexes mediating positive 
selection differ from those orchestrating negative selection will bring clarity to the debate 58, 100. 
 
Elucidation of the selecting self-pMHC ligandome has proven difficult for a variety of technical 
reasons 40. First, very few naturally occurring TCR: selecting self-pMHCII pairs have been 
identified and validated 85. Given the clear differences between CD4 and CD8 T cell 
development and maintenance 101, 102 it is critical to evaluate these two systems independently. 
Second, the rare abundance of individual thymic APC subsets compounded with the low 
concentration of any one unique selecting self-pMHC complex makes ex vivo biochemical 
analysis of these complexes challenging, and skewed toward the few most abundant self-peptides 
103. Alternative routes to investigate the self-peptide repertoire have focused on evaluating 
mRNA levels 104. Unfortunately, surveillance of eluted peptides and message levels do not 
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provide any insight as to the spatial and temporal nature of the functional unit of selecting self-
peptide in complex with MHC. Recent discoveries of TCR: selecting self-pMHCII pairs in vitro 
have opened the field for investigation of naturally occurring selecting ligands, however to date 
no studies have shown directly the presence of these ligand complexes on the selecting thymic 
APCs.  
 
It is clear that a T cell’s dependence on self-pMHC recognition does not end in the thymus. In 
addition to the clear intrathymic requirements for self-pMHC expression, continued engagement 
of TCR by self-pMHCII is required for the homeostatic maintenance of mature T cells, the 
mechanisms of which are not yet completely understood 77, 78. Studies suggest that the same 
ligands present in the thymus are utilized in the periphery for maintaining the T cell repertoire 75. 
Given that the entire life of a T cell depends on continued recognition of (selecting) self-pMHC, 
it is critical to understand the natural landscape of these complexes in the thymus and periphery. 
The technical hurdles involved with ex vivo analysis of the peptide repertoire indicate a need to 
functionally detect these selecting self-pMHC complexes in their natural environments. 
 
Our laboratory has recently identified a naturally occurring positive selecting self-pMHC for the 
ANDtg T cell, called gp250/I-Ek 1.  The gp250 self-peptide was isolated from self-peptides 
bound to I-Ek on the B cell line CH27. In the present report, we have generated a T cell 
hybridoma specific for gp250/I-Ek. Using this hybridoma, we have functionally analyzed the 
expression of naturally occurring selecting self-pMHCII complexes on thymic and peripheral 
APCs. Because T cell hybridoma responses rely solely on pMHC engagement and are not 
affected by co-stimulatory molecules, this tool will only reflect the presence of gp250/I-Ek 
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complexes on surveyed APCs. The results indicate that naturally occurring selecting ligand 
gp250/I-Ek is ubiquitously presented by positive selecting cTECs, negatively selecting mTECs 
and thymic DCs, as well as peripheral MHCII expressing APCs. These data show for the first 
time the presence of a naturally occurring selecting self-pMHCII on both cTEC and mTECs, 
suggesting that despite unique processing capabilities, positive and negative selecting thymic 
APCs do functionally present overlapping pMHC complexes. Additionally, we observed 
discrepancies between gene expression and functional complex presentation. Furthermore, the 
peripheral presentation of this selecting complex changes with recent immune status, suggesting 
the existence of a dynamic self-pMHC landscape with potential consequences to the existing 
mature T cell repertoire. These findings support a thymic selection model that merges, not 
excludes, currently proposed systems, and suggests that investigation of the self-pMHC 
landscape must include careful functional evaluation of pMHC complexes in addition to broadly 
visualizing the gene expression and eluted peptide profiles. 
 
Results 
Generation of a sensitive T cell hybridoma specific for the positive selecting ligand gp250/I-Ek 
We generated a sensitive T cell hybridoma to investigate the constitutive expression of the 
naturally occurring gp250/I-Ek positive selecting protein complex by various APCs. Attempts to 
analyze the self-peptide landscape throughout various tissues have previously been performed on 
a transcriptional level. However, mRNA expression does not always correlate with protein 
expression, and this correlation is further complicated when focusing on functional pMHC 
complexes. We sought to use a T cell hybridoma as a tool to functionally detect selecting self-
pMHCII complexes. The inability of co-stimulation to affect a hybridoma response means that 
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this tool will solely reflect the presence of self-pMHC presented by the surveyed APCs. A panel 
of hybridomas from H-2k gp250 deficient mice, primed with gp250 peptide in CFA, were tested 
for activity against the CH27 B cell line from which the gp250/I-Ek selecting complexes were 
identified biochemically. Reactive hybridomas, identified by IL-2 production after co-culture 
with the CH27 APC line, were subcloned by limiting dilution three times to achieve clonality 
(Figure 2.1).  Hybrid specificity was tested using gp250 peptide pulsed CHO-Ek APCs. Because 
this I-Ek restricted cell line very poorly presents endogenously processed peptides, we are able to 
confirm that hybridoma reactivity is specific to our peptide of interest, and not an unknown 
peptide entity. The chosen gp250/I-Ek specific T cell hybridoma (out of ~100), herein termed 
Ga2.6, expresses the Vα4 (TRAV4), Vβ1 (TRBV1) TCR with CDR3 regions that are 10 and 
12aa long, respectively (data not shown). 
 
Despite the low concentration of a given self-pMHC on an APC, this small amount of complex is 
biologically relevant, providing essential stimuli to both developing thymocytes and mature T 
cells 39, 63, 64. Because levels of most endogenously presented self-pMHC are very low, it was 
important that the chosen gp250/I-Ek specific T cell hybridoma could sensitively and specifically 
detect physiological levels of the selecting self-pMHCII complex gp250/I-Ek. The Ga2.6 
hybridoma proved extremely sensitive, producing detectable amounts of IL-2 when activated by 
as few as 1,000 cells from the CH27 B cell line, and 0.05µM peptide on pulsed CHO-Ek cells 
(Figure 2.2 A, B). Ga2.6 was tested for broad recognition of gp250 altered peptide ligands 
(APLs) at the TCR contact residues, and was shown to be completely intolerant to alterations at 
three out of four contact locations, producing no IL-2 when stimulated with respective APL 
pulsed CHO-Ek cells. Ga2.6 exhibited flexibility in peptide recognition exclusively at the P8 
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position, thus exhibiting exquisitely specific pMHCII recognition, as was described for the 
primary ANDtg CD4 T cell selected by gp250/I-Ek 1 (Figure 2.2 C). It is known that T cell 
hybridomas do not depend on adhesion molecules or co-stimulation to become activated 105. To 
verify that Ga2.6 works independently from these factors, and to survey the presentation of 
selecting self-pMHCII in the absence of adhesion or co-stimulatory molecules, we stimulated 
Ga2.6 with a soluble gp250/I-Ek monomer and noted a sensitive response to this stimulus 
(Figure 2.2 D). To confirm that recognition by Ga2.6 is I-Ek restricted, we used anti-I-Ek 
monoclonal antibodies to block Ga2.6 stimulation.  The ability of anti I-Ek 14.4.4 antibody to 
block Ga2.6 activation indicates that recognition by Ga2.6 is MHCII I-Ek restricted (Figure 2.2 
E). Together, these characteristics show that the Ga2.6 T cell hybridoma is an ideal functional 
probe for the detection of endogenously processed and presented gp250/I-Ek. 
 
Characterization of a sensitive T cell hybridoma specific for the positive selecting ligand 
gp250/I-Ek 
Detection of endogenous gp250/I-Ek was closely investigated using primary splenic or thymic 
single cell preparations from either wild type H-2k restricted or gp250 deficient H-2k restricted 
mice. Using Ga2.6, we were able to functionally detect expression of gp250/I-Ek protein 
complexes in both whole thymus and spleen from low numbers of primary cells. As expected 
based on its role in the selection of the ANDtg T cell, selecting self-pMHCII complexes were 
detected within whole thymic preparations from gp250 sufficient mice (Figure 2.3 A). Though 
peripheral expression of self-pMHC is a well-described phenomenon, the purpose of this 
peripheral expression is hitherto unknown. Using Ga2.6 as a functional tool, we sought to survey 
the peripheral expression of selecting ligand gp250/I-Ek within splenic preparations. Ga2.6 can 
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detect gp250/I-Ek complexes presented by as few as 5,000 primary splenic APCs (Figure 2.3 B). 
Importantly, single cell preparations from gp250KO/H-2k mice were unable to promote IL-2 
production by Ga2.6. Thymic and splenic preparations from B6 (I-E-negative) mice failed to 
activate Ga2.6, confirming the I-Ek specific recognition of this hybridoma (Figure 2.3).  The 
intermediary response produced upon stimulation with gp250 heterozygote splenic and thymic 
preparations, compared to B6.K mice, indicates that Ga2.6 can detect two fold differences in 
gp250/I-Ek expression (Figure 2.4). Together, these data show that endogenously processed and 
presented selecting ligand gp250/I-Ek is present in both the thymus and periphery, and can be 
detected by the T cell hybridoma Ga2.6 in a dose dependent manner. 
 
Transcript analysis predicts variable expression of the selecting ligand gp250 among APC 
subsets 
Data repositories such as NCBI Geoprofile 106 and ImmGen 107 are excellent resources for 
gaining an understanding of organism-wide gene expression. Due to the technical limitations in 
peptide analysis from small numbers of cells, transcriptome analysis is often the best available 
indicator of potential self-peptide expression. Databases indicate that LR11 mRNA, from which 
gp250 is derived, can be detected in various APC populations, including cortical and medullary 
thymic epithelial cells; notably, LR11 message is minuscule in dendritic cells from both the 
thymus and spleen (GEO: GDS4303 90, GEO: GDS1655 91, GEO: GDS297). In our hands, 
quantitative PCR analysis of LR11 expression in sorted thymic and splenic APC populations 
(Figure 2.5) confirms the expression profile described in available databases. Specifically, 
positive selecting cTECs contain abundant levels of LR11 message; negatively selecting thymic 
DCs express very low amounts while expression in mTECs is intermediary (Figure 2.6 A). LR11 
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mRNA was also detected in sorted peripheral APCs. While high expression of LR11 was 
detected in B cells, much lower levels were observed in splenic DCs (Figure 2.6 B). LR11 
message was undetected in gp250 deficient spleen and thymus.  
 
The positive selecting gp250/I-Ek complex is constitutively and efficiently presented by thymic 
APCs 
Using the Ga2.6 hybridoma, we surveyed FACS sorted thymic APCs for functional expression 
of the positive selecting self-pMHCII, gp250/I-Ek protein complexes. We detected gp250/I-Ek on 
all three thymic APC populations, cTECs, mTECs and DCs, providing a picture of the naturally 
occurring selecting self-pMHCII expression landscape (Figure 2.7 A). To our knowledge, this is 
the first demonstration of a validated and endogenous positive selecting ligand being expressed 
on both the positive selecting cTECs as well as tolerance inducing mTECs and thymic DCs. This 
close investigation of selecting ligand presentation within the thymus showed that the hierarchy 
of LR11 transcript abundance among the cells responsible for intrathymic selection (Figure 2.6) 
is not reflected in gp250/I-Ek protein complex expression, as detected by Ga2.6. Despite LR11 
transcript expression being most abundant in cTECs, significantly diminished in mTECs, and 
nearly undetectable in thymic CD11c+ DCs, the Ga2.6 hybridoma detected the most efficient 
presentation of selecting ligand gp250/I-Ek on the thymic APCs with the lowest LR11 gene 
expression. Specifically, CD11c+ DCs exhibited more potent and sensitive stimulation of Ga2.6 
than did mTECs. Meanwhile, the expression of gp250/I-Ek complexes on positive selecting 
cTECs was present, but low, as detected by the Ga2.6 hybridoma. To elucidate if differences in 
Ga2.6 stimulation by thymic APCs were due to inherent differences in peptide processing or 
simply a result of differing pMHCII expression, exogenous gp250 peptide was added to each cell 
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type, such that differences in processing would be overridden by direct loading of gp250 peptide 
onto MHCII I-Ek molecules. Ga2.6 responds similarly to peptide pulsed primary cTECs, mTEC 
and DCs, with the DCs tending to be insignificantly yet reproducibly elevated in their self-
pMHCII expression (Figure 2.7 B). This equivalent presentation of exogenous peptide indicates 
that differences in gp250/I-Ek complex expression likely arise during the endogenous processing 
of this naturally occurring ligand, and are not due to differences in pMHCII abundance. The 
hybridoma’s co-stimulation independent functionality further ensures that the differences we see 
are not due to the variable co-stimulatory capacity of the APC subsets. Of note, all three main 
thymic APC subsets express similar levels of MHCII (data not shown). These results suggest that 
the unique endogenous processing machinery of each thymic APC subset dictates the efficiency 
with which positive selecting ligand gp250/I-Ek is expressed. Overall, Ga2.6 was able to 
functionally detect selecting self-pMHCII gp250/I-Ek complexes on all thymic APCs involved in 
intrathymic selection. Notably, RNA expression did not correlate with the functional expression 
of pMHCII complexes as evidenced by Ga2.6.  
  
Constitutive presentation of the positive selecting ligand gp250/I-Ek in the periphery is affected 
by the activation state of the splenic APCs.  
Self-peptides, including positive selecting ligands, are known to be expressed in the peripheral 
lymphoid tissues and play essential roles in the survival and activation of peripheral T cells. The 
precise roles of positive selecting self-pMHCII in the periphery have yet to be unequivocally 
determined. Understanding the peripheral APC network that expresses these selecting ligands 
will be critical in elucidating their peripheral function. Immune responses occur in the periphery 
and lead to explicit changes in the APC network toward the elimination of pathogens. Of interest 
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is how the landscape of selecting self-pMHCII expression changes in response to unrelated 
antigenic stimulation. Having already established the detection of gp250/I-Ek within whole 
splenic preparations (Figure 2.3), we used the Ga2.6 hybridoma to assess the peripheral 
expression of positive selecting ligand gp250/I-Ek on specific APC subsets. B cell and DC 
populations were enriched from whole spleen by magnetic bead enrichment and FACS (Figure 
2.5). gp250/I-Ek selecting complexes were detected on both B cell and DC enriched and sorted 
populations (Figure 2.8). Similar to the thymic APC populations, the hierarchy of gp250/I-Ek 
protein complex expression did not reflect the LR11 gene expression hierarchy (Figure 2.6). 
CD11c+ DCs more efficiently present the selecting ligand, despite CD11c+ cells having 
dramatically less expression of the LR11 gene. This confirms the benefit of a system that 
functionally detects naturally occurring selecting self-pMHCII protein complexes.  Because the 
proposed roles of self-pMHC in the periphery include augmenting an immune response to 
foreign antigen, we sought to investigate any changes in the expression of selecting ligand 
gp250/I-Ek that occur as the activation state of the APCs change.  A close look at the expression 
of the selecting ligand on peripheral B cells shows that ex vivo activation leads to decreased 
presentation of gp250/I-Ek. Activating B cells using a regimen that mimics immune complex 
activation, anti-CD40/anti-IgM, reduces the efficiency of self-pMHCII expression. This 
efficiency is even more dramatically reduced upon activation through TLR 4 using LPS. (Figure 
2.9 A) We next sought to investigate any changes in the self-pMHCII landscape during the 
course of an in vivo infection. Three days post infection with Listeria monocytogenes B cells 
(Figure 2.9 A) and DCs (Figure 2.9 B) were enriched from the spleen and surveyed for gp250/I-
Ek expression. In both B cell and DC compartments, activation of Ga2.6 was reduced during 
bacterial infection. Despite dramatic reductions in the maximal IL-2 production generated in 
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response to stimulation with Listeria infected APCs, the half-maximal cell dose was similar to 
that of steady-state APCs. Given the well-established role for dendritic cells during the course of 
a Listeria infection, it was not surprising to see changes in the landscape of presented peptides 
within this APC subset. However, the reduced presentation of gp250/I-Ek by B cells was curious, 
as these cells are not known to play a role in the direct presentation of Listeria antigen on 
MHCII. To investigate the extent of Listeria pMHCII expression by B cell and DC subsets, 
Listeria specific TCR transgenic CD4+ T cells (LLO56) were co-cultured with APCs enriched as 
above. CD69 upregulation was assessed 15-20 hours later as a measure of T cell activation 
(Figure 2.9 C). As expected, DC enriched populations were efficiently presenting Listeria 
antigens as indicated by CD69 upregulation. Meanwhile, B cell enriched populations appeared to 
be presenting suboptimal levels of Listeria pMHCII. These results suggest that the landscape of 
selecting self-pMHC is a dynamic entity, experiencing antigen non-specific changes in 
expression patterns throughout the course of immune responses. 
 
Discussion 
There are several technical hurdles involved in evaluating the endogenous self-peptide 
landscape. To date, the most common insight into self-ligand expression is gained through 
transcriptional analysis. The discrepancy viewed herein between endogenous mRNA and self-
pMHCII complex expression is just one clear example of the caution required when evaluating 
the functional self-pMHC repertoire. The mechanisms behind this modulation may have a direct 
impact on the overall peptide landscape. Only recently has the presence and impact of post-
translational modifications (PTMs) on presented pMHC complexes become clear108. Some of the 
PTMs identified are regulated by immune response factors, such as inducible nitric oxide 
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synthase (iNOS)109 and have direct impacts on the immunogenicity of presented peptide 
epitopes. As such, the link between self-pMHC modifications and autoimmunity has been 
previously described110, suggesting that PTMs may explain the differences between the 
expression of mRNA and self-pMHCII complexes observed here. It is also possible that the 
variation between APC subsets can be attributed to the their unique processing machinery. 
Increasingly clear is that PTMs and MHC processing are not mutually exclusive, and that PTMs 
can directly and indirectly influence the pMHC landscape. 
 
We were able to functionally detect differences in the peripheral presentation of a single natural 
positive selecting ligand in response to a bacterial infection. Given the intricate regulation of the 
pMHC-ligandome, particularly as a result of an immune response, this is not entirely surprising. 
This suggests that the peripheral self-peptide landscape is dynamic, and has implications for the 
maintenance of the mature T cell pool. Assuming the widely held paradigm that self-pMHC, in 
particular selecting ligands, are essential for the peripheral maintenance of T cells holds true, 
dramatic reductions in the expression of a given self-pMHC might be expected to result in the 
loss of T cells dependent on that homeostatic signal. In the case of an immune response, there 
exists the potential to lose T cell pools completely unrelated to the ongoing reactions. In practice, 
this would likely not be a completely detrimental consequence. Studies with single peptide and 
selecting peptide deficient mice suggest that a single peptide or peptide family can support 
multiple T cell clones, and that non-dominant self-pMHC exist that can select a single T cell 
clone in the absence of the dominant selecting ligand 111. This would imply that peripheral T 
cells ought to receive homeostatic signals from more that one specific self-pMHC. Further work 
is needed to determine how the self-pMHC repertoire contributes to the maintenance of the 
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mature T cell pool and fits into the models of immune response driven T cell repertoire 
fluctuations 112. 
 
To our knowledge, this is the first description of the presence of a known MHCII positive 
selecting ligand that is naturally occurring on both positive and negative selecting thymic APCs. 
These data support the affinity model for how a CD4+ T cell can be positively selected on a 
"public" ligand, but not be negatively selected by the same ligand 40. The non-mutually exclusive 
possibility that some CD4+ T cells are selected by “private” class II bound peptides, uniquely 
generated by Cathepsin L or TSSP mechanisms, is not excluded by these data. How our findings 
relate to the positive selection of CD8+ T cells was not established in this study. The 
thymoproteasome, containing the β5t subunit, has been shown to generate "private" peptides in 
cTECs in addition to the “public” peptides concurrently generated. The currently growing list of 
proteases being associated with antigen processing suggests we are only beginning to understand 
the intricate mechanisms and regulation of pMHC generation 113. Given the inefficiency of 
positive selection it is likely that both "public" and "private" peptides are involved in the positive 
selection of a broad T cell repertoire. It remains to be determined if there are functional 
differences between such T cells selected on "private" or "public" peptides. "Public" peptides 
may have a specific role in the peripheral maintenance of T cells, which requires re-recognition 
of thymic self-pMHC in the periphery. What is clear from this study is that the naturally 
occurring self-pMHC landscape is intricately modulated. Complete understanding of the self-
ligandome will be critical in elucidating the exact mechanisms of thymic development and how 
this process and the ligands involved impact the T cell for life. 
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Conclusion 
We have generated a sensitive T cell hybridoma that is specific for the bona fide, naturally 
occurring gp250/I-Ek positive selecting ligand. This hybridoma is I-Ek MHCII restricted and 
specific for the gp250 epitope identified as the selecting ligand for the ANDtg CD4 T cell. Using 
this tool, we were able to assess the expression of gp250/I-Ek protein complexes in thymus and 
periphery. The efficiency of selecting self-pMHCII expression did not correlate with the levels of 
LR11 gene expression in either location. Despite nearly absent gene expression in the CD11c 
compartments of the thymus and spleen, Ga2.6 detected the most efficient presentation of 
gp250/I-Ek within these populations. To our knowledge, the detection of this naturally occurring 
selecting ligand on cTECs as well as mTECs and thymic DCs is the first unequivocal proof that 
the same self-ligand is present on both positive selecting and tolerance inducing thymic APCs. In 
the periphery, the extent of gp250/I-Ek presentation was dependent on the activation state of the 
CD19+ B cells and CD11c+ DCs, with B cells predominating in the naive setting and the DCs 
playing a bigger role in self-pMHCII presentation while in the mature sate. These findings 
suggest that despite the unique processing capabilities of the thymic APCs, they do present 
overlapping functional self-pMHCII complexes. In regards to the peripheral presentation of these 
complexes, the landscape is dynamically regulated, and depends on the recent immune status. In 
either location, evaluation of the self-ligandome should include functional detection self-pMHC 
complexes in addition to transcriptional analysis.  
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Materials and Methods 
Mice 
gp250 deficient mice 92 were bred to the B6.K (H-2k restricted) line (JAX 001148). The mice 
were extensively backcrossed to B6.K, and were monitored by the analysis of microsatellite 
markers at the Rheumatic Disease Core Center, Washington University School of Medicine (St. 
Louis, MO). The gp250 deficient mice are immunologically normal. gp250 is derived from the 
sortillin-related LDL endocytic receptor LR11, and while primary expression is in the cortical 
brain, its transcripts are expressed to varying degrees in all known APC subsets. gp250 has no 
sequence homology to ANDtg CD4 T cells’ agonist peptide MCC 1, 89. The MCC–I-Ek specific 
AND TCRtg2, B6.K (H-2k), C57BL/6 (B6, H-2b) (JAX 000664) and B6.Rag1−/− (JAX 002096) 
mice were purchased from The Jackson Laboratory. The AND TCRtg line was bred 
onto Rag1−/− background: AND.Rag1−/−H-2k.  The LLO TCRtg mice were generated in our 
laboratory as previously described 2, 24. All mice were bred and housed in specific pathogen–free 
conditions of the animal facility at the Washington University Medical Center. The use of all 
laboratory animals was approved and performed in accordance with the Washington University 
Division of Comparative Medicine guidelines. 
 
Development of gp250-Specifc T cell hybridomas 
gp250 specific hybridomas were generated by using a standard fusion protocol 55. Briefly, 
popliteal lymph nodes were taken 7 to 10 days after immunization of gp250 deficient mice in the 
hind footpads with 40 nMole of gp250 peptide emulsified in complete Freund's adjuvant H37Ra 
(BD Difco). A single-cell suspension was prepared and these bulk cultures were fused with the 
BW5147α-β- fusion partner. Successful fusions were enriched by hypoxanthine-aminopterin-
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thymidine (HAT) selection. The Ga2.6 hybridoma was subcloned three times by limiting dilution 
analysis to ensure clonality of the line. 
 
Flow cytometry and APC isolation 
For the enrichment and purification of thymic APC populations, 5-30 thymi were digested as 
previously described 114, 115. Briefly, thymi were isolated into CO2 independent media (Life 
Technologies) supplemented with 10% FCS, thymocytes were released and thymic remnants 
were digested by either stirring at 1200 rpm for 30 minutes in 0.125% w/v Collagenase D 
(Roche) at 37°C or with 1.8mg/mL Liberase TH using the gentleMACS dissociator Spleen_01 
program, followed by a 15 minute rotation at 37° and final dissociation with program Spleen_02. 
(Miltenyi). Each digest was supplemented with 0.025% w/v DNaseI (Roche). For the enrichment 
and purification of splenic B cell and DC populations, 5-10 spleens were digested as with the 
Collagenase D digested thymi above. CD45, CD11c or CD19 positive and negative populations 
were separated by magnetic bead positive selection using the respective microbeads (Miltenyi). 
CD45- and CD45+ thymic populations were stained for cTECs, mTECs and CD11c+ DCs using 
the following antibodies: UEA-1 FITC (Vector Laboratories), EPCAM (G8.8) PE, MHCII (M5) 
PECy7, Ly51 (6C3) APC, CD45.1 (A20) or CD45.2 (104) APCCy7, and CD11c (N418) PacBlue 
(eBioscience or BioLegend). Splenic populations were stained for B cell and DC populations 
using CD19 (6D5), B220 (RA3-6B2), CD11c and MHCII. APCs were sorted on the FACSAriaII 
into serum and plated at the indicated concentrations in 96-well flat bottom plates. 
 
 
 
 58 
Cell lines, peptides and monoclonal antibodies 
The CH27 (H-2a, I-Ek) B cell line, the MHCII I-Ek transfected Chinese hamster ovary (CHO-Ek) 
cell line, and the BW5147α-β- cell line, have been described 116, 117.  The CHO-Ek cells were 
cultured in MEM- α containing 5% (vol/vol) bovine growth serum (Hyclone) and 0.5 mg/ml of 
G418, and 50µM 2-mercaptoethanol. BW5147α-β- cells and the Ga2.6 hybrid generated here 
were grown in Iscove's medium containing 20% (vol/vol) FCS. Hybrids were subcloned and 
maintained in IMDM medium containing 10% (vol/vol) FCS, as were the CH27 cells. CTLL 
cells were maintained in Dulbecco's Modified Eagle Medium (DMEM) containing 5% (vol/vol) 
FCS. Media were supplemented with 2 mM Glutamax (Invitrogen) and 50µg/ml of gentamicin. 
Monoclonal antibody 14.4.4S, specific for the I-E α-chain, was obtained from the American 
Type Culture Collection and was purified from ascites fluid and used at the indicated 
concentrations 86. All peptides were synthesized, purified, and analyzed as previously described 
86. gp250 (SAPGLIIATGSVGK) and CLiP (PVSKMRMATPLLMQA) I-Ek biotinylated 
monomers were obtained from the NIH tetramer facility. 
 
Hybridoma stimulation assays 
This assay system examines the in vivo presentation of gp250 by APCs to the gp250-specific T-
cell hybridoma Ga2.6. APCs used were the CH27 B cell line, CHO-Ek cell line (105/well), or 
primary APCs isolated from enzymatically digested spleen or thymus. In the case of plate-bound 
monomer stimulations, 96-well round bottom plates were first coated overnight at 4°C with 
1µg/well streptavadin. Plates were then washed and coated with biotinylated monomer at the 
indicated concentrations, overnight at 4°C. To these was added the T-cell hybridoma Ga2.6 (105 
cells/well) in the presence or absence of exogenous gp250 peptide. APCs and hybridoma cells 
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were incubated for 15-20 hours at 37˚C in 96-well flat-bottom plate. T-cell stimulation was 
measured by quantifying the release of interleukin 2 (IL-2) by the T-cell hybridoma. IL-2 in the 
supernatant was measured by IL-2 ELISA, or by measuring [3H]thymidine incorporation by the 
IL-2-dependent CTLL line 118, 119. ELISA was performed using 100 µg/well capture anti-IL-2 
mAb (JES6-1A12; Biolegend), 50 µg/well biotinylated-anti-IL-2 detection mAb (JES6-5H4; 
Biolegend), 100 µl/well 1/10,000 dilution streptavidin-HRP (Southern Biotech), and developed 
using 100 µl/well 1-Step-Ultra tetramethylbenzidine substrate (Thermo Scientific). The reaction 
stopped at 15 min by the addition of 100 µl/well 2 M sulfuric acid, and assessed using a Victor3 
plate reader (PerkinElmer). Regression analysis of IL-2 standards using GraphPad Prism 6 
(GraphPad Software) was used to convert absorbance into amount of IL-2. Alternatively, CTLL 
cells (104 in 100µl) were added to the 100µl of supernatant and were cultured for 24-32 hours. 
Each well was pulsed with 0.2µCi of [3H]thymidine during the final 6 hr of culture, and plates 
were harvested and [3H]thymidine incorporation was measured.  
 
T cell receptor sequencing and quantitative PCR 
RNA was isolated with an RNeasy kit (Qiagen) from cell lines and splenic or thymic APCs 
enriched through the use of magnetic-activated cell sorting beads and purified by flow 
cytometric sorting. cDNA was synthesized using random hexamer primers (SuperScript II kit; 
Invitrogen). TCR were amplified as previously described 120. Briefly, nested PCR was used to 
amplify TCR α and β transcripts 121, which were bulk ligated into pCR2.1 TOPO sequencing 
vector, sequenced, and analyzed using Lasergene 8 (Invitrogen, Genewiz, DNASTAR). For 
quantitative PCR analysis, SYBR Green PCR master mix and ABI7000 machinery (Applied 
Biosystems) were used as previously described 122. Cycling conditions were 50 °C for 2 min, 
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followed by 95 °C for 10 min, 40 cycles of 95 °C for 15 s, and a dissociation stage (95 °C for 15 
s, 60 °C for 20 s and 95 °C for 15 s); β-actin was included as internal control for all samples. 
Changes were calculated by the ΔΔCT method with CH27 B cell line samples as the baseline 
sample and Actb as the reference gene. The following primers (5′ to 3′; forward and then reverse) 
were used: LR11, GGGAATTTCTTCAGGCCCCA and TCCGAAGTTGGAGGTTGAGC; β-
actin, CTAAGGCCAACCGTGAAAAG and ACCAGAGGCATACAGGGACA. 
 
Bacterial infections and in vitro activation 
The Listeria monocytogenes strain 10403S was used in this study. Frozen stocks of L. 
monocytogenes in PBS plus 20% glycerol were thawed and serially diluted to a density of 
1x104 colony-forming units (CFU) per ml in PBS. Mice were infected three days prior to APC 
isolation retro-orbitally with 103 CFU L. monocytogenes 52. For ex vivo activation, enriched 
splenic B cells were stimulated in 6-well plates with 10µg/mL anti-CD40 and 10µg/mL anti-IgM 
F(ab)2, or 20µg/mL LPS for 48 hours at 37°C 123.  
 
Analysis of Listeria specific response 
For analysis of Listeria specific response, LLO56 CD4+ T cells purified by magnetic bead 
positive selection were cultured with varying amounts of sorted CD11c+ DCs or CD19+ B cells 
from the spleens of naive or Listeria infected mice in triplicate, in 96 well plates. After 15-20 
hours at 37°C in 5% CO2 in Iscoves medium containing 10% FCS, CD4+ T Cells were analyzed 
for upregulation of CD69 by flow cytometry. 
 
 
 61 
Figure 2.1. Isolation and subcloning of Ga2.6 hybridoma. (A) Greater than 85 hybridomas 
were tested for reactivity against the CH27 B cell line as measured by IL-2 production; 12 were 
selected for further investigation. (B) Sensitive hybridomas were subcloned and tested for 
reactivity to high doses endogenously processed gp250/I-Ek from whole spleen. 
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Figure 2.1. Isolation and subcloning of Ga2.6 hybridoma. 
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Figure 2.2. Ga2.6 hybridoma response is specific for gp250/I-Ek. Enzyme-linked 
immunosorbent assay (ELISA) of IL-2 produced by Ga2.6 detecting gp250/I-Ek in overnight 
culture with the indicated number of  (A) CH27 B cell lymphoma line (B) exogenous gp250 
peptide presented by 105 CHO-Ek cells or (C) gp250 altered peptide ligands with proline 
mutations at TCR contacts presented by CHO-Ek. (D) IL-2 production by Ga2.6 stimulated 
overnight with plate-bound gp250/I-Ek monomer. (E) 5x105 whole splenocyte or thymic cells 
cultured with (black bars) or without (white bars) anti-MHCII clone 14.4.4; Ga2.6 activation was 
measured by IL-2 response. N.D. = not detected. Data are representative of at least 3 experiments 
and depict mean ± SEM.  
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Figure 2.2. Ga2.6 hybridoma response is specific for gp250/I-Ek. 
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Figure 2.3. Ga2.6 sensitively detects endogenous gp250/I-Ek complexes. Detection of 
gp250/I-Ek complexes from titrated doses of single cell (A) thymic or (B) splenic preparations by 
IL-2 ELISA of Ga2.6 culture supernatant. Mice expressed gp250/I-Ek (B6.K-black circles), I-Ek 
without gp250 (gp250 KO-triangles) or gp250/I-Ab (B6-crosses). Data are representative of at 
least 3 experiments and depict mean ± SEM. 
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Figure 2.3. Ga2.6 sensitively detects endogenous gp250/I-Ek complexes. 
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Figure 2.4. Ga2.6 recognizes endogenous differences in gp250/I-Ek doses. IL-2 production, as 
measured by ELISA, indicates intermediary detection of gp250/I-Ek complexes from the 
indicated number of  (A) spleen and (B) thymus single cells from gp250 heterozygote mice, 
compared to homozygote and deficient littermate controls. Data are representative of at least 
three experiments and depict mean ± SEM. 
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Figure 2.4. Ga2.6 recognizes endogenous differences in gp250/I-Ek doses. 
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Figure 2.5. Thymic and splenic APC sorting strategy. (A) cTECs, mTECs were gated as 
CD45-, EPCAM and MHCII+, then CDR1+ or UEA-1+ respectively. Thymic DCs (tDC) were 
gated as CD45+, CD11c and MHCII+. (B) Splenic B cells were gated as CD19+, then B220 and 
MHCII+, while splenic DCs (sDC) were gated as CD19-, then CD11c and MHCII+. 
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Figure 2.5. Thymic and splenic APC sorting strategy. 
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Figure 2.6. Variable LR11 gene (encoding gp250) expression in thymic and splenic APCs. 
Quantitative RT-PCR analysis of LR11 mRNA expression in various FACS sorted (A) thymic 
and (B) splenic APC populations; results are presented as ΔΔCT fold change relative to Actb 
(encoding β-actin) with CH27 as the baseline sample. tDC = thymic CD11c+ DC, sDC = splenic 
CD11c+ DC. Data are representative of two-three experiments and depict mean ± SEM. 
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Figure 2.6. Variable LR11 gene (encoding gp250) expression in thymic and splenic APCs. 
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Figure 2.7. Ga2.6 detects endogenous gp250/I-Ek complexes on positive and negative 
selecting thymic APCs. IL-2 production by Ga2.6 after overnight culture with FACS sorted 
thymic APCs (equivalent numbers of DC, mTEC, or cTEC) in the (A) absence or (B) presence of 
exogenous gp250 peptide. gp250/I-Ek detection is measured via [3H]thymidine incorporation 
during the IL-2 dependent proliferation of CTLL cells. To accommodate for experimental 
variation in maximal cTEC recovery and IL-2 production, equal numbers of all thymic APCs, 
ranging from 4,000-15,000, were utilized within each assay. Data were normalized to the 
maximal [3H]thymidine incorporation in each experiment. Data are a compilation of five 
experiments and depict mean ± SEM. One-way Anova, **P<0.01, ***P<0.0001. 
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Figure 2.7. Ga2.6 detects endogenous gp250/I-Ek complexes on positive and negative 
selecting thymic APCs. 
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Figure 2.8. Ga2.6 detects gp250/I-Ek complexes on peripheral splenic APCs. (A) IL-2 
production by Ga2.6 measured after overnight culture with FACS sorted splenic B cells and 
DCs. (B) EC50 indicates the number of APCs required to produce a half-maximal IL-2 response. 
Data are representative of three experiments and depict mean ± SEM. Mann-Whitney test, 
**p<0.01. 
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Figure 2.8. Ga2.6 detects gp250/I-Ek complexes on peripheral splenic APCs. 
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Figure 2.9. Expression of gp250/I-Ek is affected by the recent immune status. IL-2 
production by Ga2.6 in response to (A) B cells activated ex vivo using anti-CD40 and anti-IgM 
or LPS for 48 hours prior to co-culture with Ga2.6. Alternatively, in vivo activated B cells and 
(B) DCs were harvested from the spleens of B6.K mice infected with Listeria monocytogenes 
three days prior to co-culture with Ga2.6. (C) Presentation of Listeria-pMHCII as measured by 
CD69 upregulation (mean fluorescence intensity-MFI) on LLO specific CD4 TCRtg T cells 
stimulated with B cells or DCs from Listeria mice. Data are representative of at least three 
experiments and depict mean ± SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 78 
10
3
10
4
10
5
10
6
10
7
0
500
1000
1500
2000
Splenic B Cells (#/well)
IL
-2
 P
ro
du
ct
io
n 
(p
g/
m
L)
Naive
Listeria
IgM + CD40
LPS
10
3
10
4
10
5
10
6
10
7
0
500
1000
1500
Splenic DCs (#/well)
IL
-2
 P
ro
du
ct
io
n 
(p
g/
m
L) Naive
Listeria
103 104 105 106
0
50
100
150
200
250
Sorted Spelenic APCs (#/well)
Li
st
er
ia
 R
es
po
ns
e
 
(M
F
I C
D
69
) B Cells
DCs
A B
C
 
Figure 2.9. Expression of gp250/I-Ek is affected by the recent immune status.  
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CHAPTER III 
 
Intravital, in situ imaging of the murine thymus 
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This chapter represents work completed in collaboration with the laboratory of Mark J. 
Miller. The surgical technique described herein is performed by Yizheng Tu. 
 
 
Introduction 
Migration and cell-cell interactions are a vital component of both adaptive and innate immunity. 
Whether in the earliest stages of development and tissue seeding of hematopoietic cells, the 
critical circulation of these effector cells when surveying the body for pathogens, or the cellular 
dynamics that occur during an active immune response, the choreography of immune cells is 
critical to their function. Two-photon microscopy has ushered a transition from the static 
evaluation of cellular interactions to the real-time visualization of live cells124, 125, 126, 127. This is 
particularly valuable for the study of T cell development, a process that depends intimately on 
the interaction of developing cells with the thymic microenvironment. The stages of thymocyte 
development occur in distinct locations within the thymus14, 15, 16. Studies of explanted thymi 
suggest that the stromal network act as roads guiding developing thymocytes as well as scaffolds 
for thymic dendritic cells to adhere128. Indeed, disruptions of thymic three-dimensional 
architecture are directly linked to inefficient development of the T cell repertoire. In addition to 
three-dimensional architecture, in vitro organ cultures require the supplementation of various 
soluble factors to support the development of mature T cells129. As such, unequivocal elucidation 
of intrathymic dynamics requires investigating these processes in the native thymic environment, 
complete with known and unknown endogenous cues.  
 
Early studies, predating the use of two-photon microscopy in the study of immunology, showed 
that the thymus was composed of an intricate three-dimensional epithelial network130, 131.  Using 
standard histological, immunohistochemical and electron microscopy techniques, it was 
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appreciated that the thymic epithelial cells were distinct from the typical flat, two-dimensional, 
basement membrane anchored epithelial networks observed in other organs132. Within these 
intricate sponge-like networks exist clusters of developing thymocytes, and the cross talk 
between these developing T cells and the thymic stroma is well documented. Specifically, 
observations of cortical and medullary thymic structure before and after hematopoietic 
reconstitution of immunodeficient mice indicated dynamic restructuring of the epithelia 
compartments with the addition of bone marrow derived cells133. The plasticity of cortical and 
medullary epithelia cells depends on thymocytes of specific developmental stages to coordinate 
the unique three-dimensional environment supporting efficient T cell development; the reversion 
from three-dimensional to two-dimensional stromal architecture was observed in conjunction 
with early blockage in thymocyte development 134, 135, 136, 137. It is clear that the interdependence 
of thymocytes and the thymic stroma to generate a three-dimensional microenvironment dictates 
efficient T cell development, however the exact mechanism of this regulation are still largely a 
mystery. 
 
Despite the lingering questions regarding intrathymic cross talk, progress has been made toward 
elucidating the endogenous cues that coordinate T cell development within the thymic 
microenvironment. Immunohistochemical analysis suggests that the spatial relationship of 
medullary thymic APCs around intermediate, but not large thymic vessels or capillaries, suggest 
that unique vascular derived cues may contribute to intrathymic dynamics138.  Aside from 
vascular clues, there is also a known interaction between the neuroendocrine and immune 
systems139. Specifically, it is thought that growth hormone increases both the thymic migration 
of developing thymocytes as well as the output of mature T cells23, 140. Other than a handful of 
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chemokines, the soluble factors that orchestrate intrathymic dynamics are poorly understood and 
difficult to investigate ex vivo. 
 
Studying the contributions of endogenous cues to the development of mature T cells using 
current imaging approaches is inadequate due to the explanted or ectopically expressed nature of 
the thymus being visualized. In valiant attempts to visualize the specific interactions that mediate 
the effective development of a mature T cell repertoire, a number of creative techniques have 
been employed in conjunction with two-photon imaging. Explantation and imaging of whole and 
sliced thymi have offered tremendous insight into the thymic architecture and likely migratory 
behavior of developing thymocytes19, 21, 141, 142. Though valuable, systems such as the thymic 
slices, which require slicing explanted thymi with a Vibratome and the addition of exogenous, 
sorted donor thymocytes to oxygen perfused slices, involve dramatic changes to the thymic 
architecture and supply of endogenous cues. In attempts to generate more physiologic conditions, 
some groups have used two-photon microscopy to image ectopically transplanted thymi in the 
kidney capsule to study thymic development143. Though all of these techniques have led to new 
insights into intrathymic cellular dynamics, none are able to completely reproduce the intact 
thymic microenvironment, and it is known that in vitro T cell selection systems do not perfectly 
mimic the endogenous process. Technical difficulties have also hindered the intravital, in situ 
visualization of thymic development thus far. The location of the thymus, within the 
mediastinum, makes it particularly difficult to image while avoiding cardiac and respiratory 
movement that impedes high-resolution time-lapse imaging144. Herein, we describe a novel 
technique that will allow for live imaging of a mouse thymus with complete, in situ vasculature 
and innervation while minimizing motion artifacts. Outlined below is a detailed description of 
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the surgical procedure used to access the thymus with intact vasculature while minimizing 
cardiac and respiratory movement for the purpose of two-photon intravital imaging. 
 
Detailed technical protocol 
All of these imaging experiments are terminal procedures, and the animals are euthanized 
immediately following the end of image acquisition. 
 
1. Anesthetize animals with Avertin (tribromoethanol) 150mg/kg intraperitoneally.  
2. Shave the fur from the chest and place mice on the imaging stage with temperature 
control capabilities 
3.  Endotracheally intubate and mechanically ventilate the animals with a rodent ventilator 
(120 breaths/min and with a tidal volume of 0.5 mL).  
4. Perform a thoracotomy using standard procedures to expose the heart and thymus.  
5. In order to prevent respiratory and cardiac function from creating movement artifacts 
during imaging, insert a thin piece of surgical cotton above the pericardial sac and below 
the thymus to act as a "tissue sling". Cautiously avoid thymic vessels and internal 
thoracic artery as well as neighboring cardiac vessels that line the thymus.  
6. Attach the spring loaded imaging slide and secure it near the thymus capsule.  
7. Ensure the tissue sling is situated without disruption of the thymic vasculature and the 
imaging slide is proximal to the thymus, and then gently lift at both ends to elevate the 
thymus above the heart (Figure 3.1 A, B).  
8. Adjust the surgical cotton such that the maximal amount of thymic tissue is in contact 
with the imaging slide.  
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9. To maintain the thymus’ position above the pericardial sac and in contact with the 
imaging slide, attach each end of the tissue sling to the imaging slide using super glue. 
10. Administer 655 nm non-targeted quantum dots 20µl in 100µl PBS (Invitrogen) 
intravenously after the surgical preparation to confirm that healthy blood flow is intact.  
11. Add the animal stage to the microscope (Figure 3.1 C). 
12. Turn on heaters and ensure that the temperature is maintained at 37°C. 
13. Continually monitor the animal for sustained anesthesia. Administer additional doses of 
anesthesia as needed.  
14. After image acquisition, euthanize animals in accordance with approved laboratory 
protocols. 
 
Technical considerations 
Animal viability must be closely monitored for effective intravital imaging. Over the course of 
imaging anesthesia will wear off; care must be taken to ensure the animal remains properly 
anesthetized. In addition, it is important to monitor the animal’s body temperature. Automated 
regulation of the imaging stage temperature should be used to maintain body temperature during 
imaging and the mouse given saline subcutaneously to prevent dehydration.  
 
The key technical advance in this approach is the use of the tissue sling that minimizes cardiac 
and respiratory movement artifacts on the thymus and permits the in vivo visualization of 
intrathymic single-cell dynamics. The amount of pressure used when securing the imaging slide 
will directly impact both the blood flow to the thymus and well as the motion artifacts. If blood 
flow is impaired, as assessed by bright field observation or the flow of quantum dots in vessels 
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using two-photon, then the pressure being exerted on the thymus must be reduced by releasing 
slightly the spring loaded imaging slide until robust tissue perfusion is restored. Contact between 
the thymus by the upper imaging slide is important for dampening undesired thymic movement 
due to heart and lung functions, so a balance must be struck between stability and good tissue 
perfusion. Within stable preparations, tissues depths of over 300µm have been evaluated (Figure 
3.2). 
   
Results 
Direct comparison of intravital in situ and explant thymic preparations 
Common methods of studying intrathymic cellular dynamics require continued perfusion of 
thymic preparations with media saturated with oxygen. Given that cell motility in ex vivo thymic 
preparations may be affected by non-physiological oxygen concentration, temperature and tissue 
manipulation, it is important to compare results between explant and in vivo imaging 
approaches124, 129.  In the case of T cell dynamics in peripheral lymph node, intravital and 
explanted data are in close agreement145, 146, 147, 148. To investigate how this novel technique 
compares with common thymic explant procedures, we have employed a previously unpublished 
reporter mouse, B6.CD69YPET. 
 
Thymocyte dynamics upon positive selection have been extensively studied in explanted 
systems16, 19, 149. Given that thymocyte CD69 expression is an early indicator of positive selection 
by self-pMHC, we sought to use a CD69 reporter mouse, expressing YPET from the CD69 
promoter, to compare the intrathymic dynamics of post-positive selection thymocytes in 
explanted and intravital, in situ thymic imaging preparations28, 47. We first confirmed by flow 
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cytometry that YPET expression correlated with CD69 expression in these thymocytes (Figure 
3.3). As expected, post-positive selection DP and SP thymocytes expressed YPET in correlation 
with CD69. There was a low level of YPET expression in the DN compartment, and this was 
correlated with the CD25+ DN2 and DN3 populations. Given the low abundance of these cells 
within the thymus and the low intensity of YPET expressed, they do not contribute significantly 
to the YPET+ thymocytes observed in the thymus.  
 
In vitro investigation of the timing of YPET induction on reporter thymocytes after non-specific 
stimulation was performed using CD69YPET/ANDtg/Ragd/d reporter thymocytes.  In these mice, 
the H-2d non-selecting background forces ANDtg thymocytes to arrest at the pre-positive 
selection, CD69 negative DP stage (Figure 3.4 A).  These assays indicated that YPET surface 
expression occurs as early as one hour post stimulation, reaching a maximum level by 3.5 hours 
as detected by flow cytometry. YPET expression accurately traces CD69 expression as measured 
by flow cytometry, represents roughly 50% of total surface CD69 expression. This is useful for 
two-photon analysis as it will reduce the total number of fluorescent cells observed within the 
thymus, allowing for the identification of unique cellular events. A single-cell suspension of 
these cells visualized by confocal microscopy showed maximal YPET expression after roughly 6 
hours of stimulation (Figure 3.4 B, C). Having confirmed that the B6.CD69YPET reporter reflects 
the known expression pattern of CD69 in thymocytes and that endogenous YPET expression can 
be observed using confocal microscopy, we used this tool to compare explanted and intravital, in 
situ intrathymic cellular dynamics after positive selection using two-photon microscopy.  
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Post-positive selection YPET+ thymocyte dynamics can be visualized using standard two-photon 
imaging of the novel thymic preparation described above. These cells are tracked as previously 
described using Imaris analysis software (Figure 3.5 A). Immediately following intravital, in situ 
image acquisition, we excised the contralateral thymic lobe and perfused it with warm 
oxygenated media in accordance with common thymic explant procedures. Imaging and tracking 
of post-positive selection thymocytes within these explanted lobes was performed as with the 
intravital preparation (Figure 3.5 B). The cellular dynamics of both preparations were quantified 
using two-photon analysis software developed by the Miller laboratory (in collaboration with 
Johannes Textor, University of Utrecht). Unlike published data showing similar T cells dynamics 
between intravital and explanted peripheral lymph nodes, we observed reduced migratory 
dynamics of post-positive selection thymocytes in the intravital, in situ thymus preparation 
compared to the explanted lobe (Figure 3.6). While explanted thymi showed mean velocities of 
6µm/min, intravital imaging revealed a slower average velocity for 4µm/min along with a 
reduction in track straightness. These data suggest that current explant and ectopic techniques 
may overestimate the migratory behavior of developing thymocytes, and highlight the usefulness 
of this novel surgical preparation and imaging technique. 
 
Visualization of thymic entry 
To date, studying the entry of thymic seeding cells by two-photon microscopy has not occurred 
because in situ thymic preparations with intact vasculature have not been possible. The novel 
intravital, in situ thymus preparation described herein allows for the real-time visualization of 
thymic entry and seeding. Bone marrow was isolated cyan fluorescent protein (CFP) transgenic 
mice (Jackson 004218) and adoptively transferred by retro orbital injection into recipient mice 
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that have been prepared for thymus imaging as described above.  Within 15 minutes, CFP+ bone 
marrow derived cells are observed within the thymus vasculature, visualized by the injection of 
quantum dots (Figure 3.7 A). Over time, CFP+ cells are also found outside of vessels and within 
the thymic stroma, indicating that these cells have undergone extravasation. Tissue resident cells 
have been identified as early as two hours after intravenous administration. To our knowledge, 
this is the first report in which thymic seeding cells have been observed entering the thymus via 
endogenous vasculature in vivo. Unlike ex vivo analysis, where the circulation is lost, intravital 
imaging of the thymus allows the earliest steps of thymocyte trafficking to be studied for the first 
time. Moreover, in vivo imaging will permit thymocyte development to be studied in the native 
context of important autocrine and paracrine regulators of selection, as well as distal endocrine 
cues coming from the circulation. 
 
Cells that are entering the thymus can be observed and tracked at various stages of extravasation 
(Figure 3.7 A,B). We inquired whether trafficking of bone marrow derived cells via the blood 
and into the thymus resembled the behaviors observed in earlier studies of leukocyte homing to 
peripheral tissues150, 151, 152. Within the blood vessels, some cells were moving at rapid speeds, 
and appear only as flashes during time-lapse imaging and as a sequence of spots within a 15 
frame averaged z-step (Figure 3.7 A, right). Taking advantage of the known frame rate of our 
system (~25f/sec), these velocities were measured; each spot corresponds to a single video-rate 
frame and the distance between them equals the distance traveled in 1/25th of a second. Using 
this method, intravascular cells were found to move between 8-90 µm/s. Though this velocity is 
much quicker than the average velocities observed of lymphocytes in tissues, it is slower than the 
reported circulating velocity of neutrophils150. In addition to rapidly circulating bone marrow 
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derived cells, CFP+ cells were observed rolling and adhering within the vessels and perivascular 
space, and these dynamics could be quantified (Figure 3.7 C). As such, we have described a 
novel technique in which the earliest events of thymic entry can visualized and quantified. This 
methodology will open the door to future investigation into the mechanisms and control of T cell 
precursor thymic entry. 
 
Conclusions 
We have generated a method to perform intravital live imaging of the intact thymus. We used a 
novel "tissue sling" surgical preparation that minimized respiratory and cardiac induced 
movement artifacts that hinder thymus imaging and have performed successfully the first 
intravital, in situ analysis of intrathymic thymocyte dynamics. To compare the migratory 
behavior of thymocytes in explanted thymi and the thymi of live mice, we used a previously 
unpublished reporter mouse, B6.CD69YPET. This reporter faithfully represents CD69 expression 
on developing thymocytes. Our data suggest that explanted and ectopic thymic preparations may 
overestimate the velocity and migratory behavior of developing thymocytes, perhaps due to 
endogenous factors that are missing or altered during tissue explanation. Using this novel thymic 
preparation, it is now also possible to visualize the initial steps of cell entry into the thymus. 
Because the endogenous cues that mediate thymocyte development in vivo are incompletely 
understood, and in vitro selection models do not fully replicate in vivo thymic selection, intravital 
in situ imaging approach, such as the one described here, will be important in understanding the 
role of thymic vasculature, innervation and tissue environment on thymocyte trafficking and 
development. 
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Discussion 
Published data indicate that thymocytes exhibit slow and random movement before positive 
selection. Explanted and slice preparations estimate mean speeds of 3-8µm/min and varied 
direction before positive selection. After dwelling while in contact with positive selecting 
cTECs, post-positive selection thymocytes are then thought to move rapidly, greater than 
13µm/min, and in a straight and directed fashion toward the medulla18, 19, 153. Our intravital data 
indicate post selection, YPET+ thymocytes moving akin to published data for pre-selection cells, 
roughly 3µm/min in a random manner. Though our explanted preparations showed increased 
thymocyte motility compared to intravitally imaged tissues, around 6µm/min, speeds were still 
lower than expected from published data. However, similarly to published data, post-selection 
YPET+ thymocyte tracks were straight. 
 
Discrepancies in observed migration dynamics between laboratories could be attributed to 
different acquisition rates and time resolutions. Additionally, perfusion, oxygenation, and 
temperature have been reported to variably affect lymphocyte dynamics in lymph nodes; 
differences of only a few degrees can have a dramatic impact on cell behavior. Future work in 
visualizing thymocyte development should address these components and their affect on cell 
motility directly. A caveat to the approach is that it wasn't possible to verify that the thymus 
temperature was at the core body temperature.  However, we do not expect the thymus 
temperature to be far outside the physiological range as the water-dipping objective uses a highly 
insulating ceramic face to minimize heat loss, blood flow is robust and warming the upper 
imaging plate had no noticeable effect on cell motility. The temperature of explanted tissues can 
be more tightly regulated, yet even when tissues were at 37 degrees C, cell migration speeds 
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were substantially less than published values using different imaging preparations, suggesting 
that although temperature is an important factor, it cannot completely explain the decreased 
motility we observed. The addition of heating elements to the top imaging slide, as well as 
measuring mouse body temperature during imaging using a rectal thermometer, would help 
verify that physiological temperature is maintained during intravital imaging. 
 
Elevating the thymus above the pericardial sac to avoid cardiac and respiratory movement from 
interfering with imaging is a significant component of this technique, as even under anesthesia, 
these movements can impeded image acquisition. Slight adjustments of the pressure used to 
stabilize the spring-loaded imaging slide can dramatically change any undesired movement that 
remains after thymus elevation. Being able to eliminate cardiac and respiratory motion while 
keeping the blood flow intact allows the visualization if thymic seeding cells entering from the 
blood. While this technique maintains the endogenous thymic environment and cues, it is not 
without its caveats. It should be noted that the surgical process itself and mode of anesthesia may 
affect lymphocyte motility, and as previously discussed, temperature regulation must still be 
carefully monitored as with previous thymus imaging techniques124, 154.  
 
In a short time, two-photon microscopy has led to incredible advancements in how the immune 
system is thought to function. As more and more critical questions are being addressed with 
immunoimaging, the technology is continuing to advance, making strides to overcome previous 
limitations such as the depth, length, and time resolution at which real time imaging can occur142, 
155. Generation of fluorescent reporter systems that unambiguously mark specific cells and can 
reflect intracellular dynamics are also expanding the scope of questions being investigated by 
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two-photon microscopy156, 157. Access to and stability of organs to be imaged has also been a 
limitation. We developed an intravital, in situ technique to overcome this hurdle in regards to the 
thymus, which will allow for important advances in studying intrathymic cellular events and 
their regulation.    
 
Methods 
Mice 
B6.129 (ICR)-Tg (CAG-ECFP) CK6Nagy/J ActinCFP mice (Jackson 004218) and 
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J (Jackson 007576) were bred to the B6.K (H-2k 
restricted) line (Jackson 001148) to generate what we refer to as ActinCFP  and RosatdTom mice 
respectively. B6.CD69YPET transgenic reporter mice were generated in Andrey Shaw’s laboratory 
by using a BAC transgene in which YPET was inserted at the initiating methionine of the CD69 
gene. CD69YPET reporter mice have also been bred to ANDtg/Ragd/d mice for use in in vitro 
assays, and are referred to as CD69YPET/ANDtg/Ragd/d; note that these thymocytes are blocked at 
the pre-selection DP stage of development. All mice were bred and housed in specific pathogen–
free conditions of the animal facility at the Washington University Medical Center. The use of all 
laboratory animals was approved and performed in accordance with the Washington University 
Division of Comparative Medicine guidelines. 
 
Bone marrow isolation 
Femurs and tibias of ActinCFP reporter mice were cut at the ends and flushed with PBS using a 
21G needle and syringe to generate a single cell suspension. Cells were centrifuged at 1200 RPM 
 93 
for 5 minutes and resuspended in PBS. 1-5x107 unfractionated bone marrow cells were injected 
intravenously into recipient B6.K mice for intravital imaging. 
 
In vitro CD69 upregulation assay 
1x106 CD69YPET/ANDtg/Ragd/d DP thymocytes were plated in 96-well round bottom plates and 
stimulated with 100 ng/ml PMA (Sigma-Aldrich) plus 1 µg/ml ionomycin (Sigma-Aldrich) for 
the indicated times. Placing the cells on ice stopped the stimulation, and staining was performed 
to analyze the timing of CD69 expression by flow cytometry 
 
Antibodies 
The following antibodies were used for flow cytometry: Live/Dead UV-Violet (Invitrogen), anti-
CD4 (RM4-4, RM4-5 and GK1.5), anti-CD8 (53-7.8), anti-CD69 (H1.2F3), anti-CD25 (PC61), 
CD44 (IM7) anti-CD5 (53-7.3) from eBioscience or Biolegend. 
 
Confocal Microscopy 
For confocal analysis, 2x107 CD69YPET/ANDtg/Ragd/d DP thymocytes were plated in 35mm 
glass microwell dishes (MatTek). Images were acquired every minute in 4 fields of focus for 3 
hours. CD69YPET/ANDtg/Ragd/d DP thymocytes were stimulated with PMA/I as above to 
visualize the initiation, rise and maintenance of YPET expression in CD69YPET/ANDtg/Ragd/d 
DP thymocytes. The baseline CD69YPET expression level was established prior to addition of 
PMA/I. 
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Two-Photon microscopy data acquisition and analysis 
Time-lapse imaging was performed with a custom-built dual-laser video-rate two-photon 
microscope as previously described99, 150. Quantum dots (Invitrogen) as well as tdTomato, YPET 
and CFP labeled cells were excited with a Chameleon XR Ti:sapphire laser (Coherent) and 
visualized with an Olympus XLUMPlanFI 20× objective (water immersed, numerical aperture, 
0.95). YPET positive cells were excited by a laser tuned to 920 nm, CFP and tdTomato and 
fluorescence were excited using a laser tuned to 820 and 1000 nm respectively. Fluorescence 
emission was separated passing through 510- and 560-nm dichroic mirrors placed in series and 
detected as red (560–650 nm), green (490–560 nm), and blue (second harmonic) signal (<458 
nm) channels by three head-on Bialkali photomultiplier tubes (PMTs). A customized version of 
ImageWarp (A&B Software) was used during real-time acquisition to process and archive the 
image data. To create time-lapse sequences, we scanned volumes of tissue in which each plane 
consists of an image of 100 × 120 µm (x and y = 2 pixel/µm). Z-stacks were acquired by taking 
31 or 121 sequential steps at 2.5µm spacing at 27–35-s intervals for up to 20 min. To increase 
signal contrast, we averaged 15 video frames for each z-slice. Multidimensional rendering and 
cell tracking was performed with Imaris (Bitplane). Statistical analysis was performed using 
GraphPad Prism 6 (GraphPad Software) and 2Ptrack.net (Miller laboratory and Johannes 
Textor). 
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Figure 3.1. Intravital, in situ thymus imaging setup.  
(A) Diagram and (B) image depicting how exposure of the thymus is achieved for intravital, in 
situ imaging. After opening the thoracic cage, surgical tissues is used to gently lift the thymus 
away from the pericardium. Care is taken to avoid the local vasculature. (C) Complete imaging 
setup showing (from left to right, red asterisks) ventilator mask, spring-loaded imaging slide over 
thymus, objective and temperature regulation probe(s). 
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Figure 1 Intravital, in situ thymus imaging setup. 
(A) Diagram and (B) image depicting how exposure of the thymus is 
achieved. After opening the thoracic cage, surgical tissues is used to 
gently lift the thymus away from the pericardium. Care is taken to avoid 
the local vasculature. (C) Complete imaging setup showing (from left to 
right, red astricks) ventilator mask, spring-loaded imaging slide over 
thymus, objective and temperature regulation probe(s).
 
Figure 3.1. Intravital, in situ thymus imaging setup.  
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Figure 3.2. Quality of intravital thymus imaging.  
Live imaging of RosatdTom Rag-/- reporter thymus at 1000nm shows (A) an imaging depth of over 
300µm (121 z-steps) (B) z merged rendering (ez3D, Imaris). (C) Intravital imaging of B6.K 
thymi immediately after intravenous injection of quantum dot 655 reveals maintenance of blood 
flow within thymic tissue and the absence of detrimental cardiac or respiratory movement. 
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Figure 3.2. Quality of intravital thymus imaging.  
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Figure 3.3. Evaluation of B6.CD69YPET reporter representation of CD69 surface expression. 
Flow cytometry with a panel of standard thymocyte development markers was used to assess the 
endogenous expression of YPET as an indicator of CD69 expression. (A) Standard gating of 
single positive (left) double negative (middle) and pre- or post-positive selection double positive 
(right) thymocytes is shown. (B) YPET (right) and surface antibody stained (left) levels of CD69 
expression in the indicated thymocyte populations. (C) Quantification of frequency (left) and 
absolute number (right) of the indicated thymocyte populations. 
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Figure 4 Evaluation of B6 CD69YPET reporter mice for the use in post-positive selection thymocyte analysis. 
Flow cytometry and a panel of standard thymocyte development markers were used to assess the endogenous expression of 
YPET as an indicator of CD69 expression. (A) Standard gating of single positive (left) double negative (middle) and pre- or 
post-positive selection double positive (right) thymocytes is shown. (B) YPET (right) and surface antibody stained (left) levels 
of CD69 expression in the indicated thymocyte populations. (C) Quantification of frequency (left) and absolute number (right) 
of the indicated thymocyte populations.
 
 
Figure 3.3. Evaluation of B6.CD69YPET reporter representation of CD69 surface expression. 
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Figure 3.4. In vitro analysis of CD69YPET expression after non-specific stimulation.  
(A) Thymocytes (right) are arrested at the DP stage of development compared to B6.K 
thymocytes (left). (B) Time course of surface (red and black) and YPET (yellow and grey) CD69 
expression in reporter positive (Rptr+) or control (Ctrl) DP thymocytes stimulated with PMA/I 
for the indicated time. (C) Intensity of YPET expression detected by confocal microscopy after 
stimulation with PMA/I. Note that YPET intensity decrease dramatically upon cell death. Data 
are representative of 2-5 experiments. 
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Figure 3.4. In vitro analysis of CD69YPET expression after non-specific stimulation.  
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Figure 3.5. Intravital, in situ imaging and analysis of post-positive selection thymocytes. 
Still representations of live two-photon imaging of the B6.CD69YPET reporter thymus after the 
intravenous administration of quantum dot 655. Full view (left) of endogenous thymocytes from 
(A) intravital or (B) explanted thymi are shown. For analysis purposes, a representative quarter 
of the entire video (middle) was fully analyzed using Imaris spot tracking. Representative track 
data are shown (right). Bars indicate 50µm. 
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Figure 3.5. Intravital, in situ imaging and analysis of post-positive selection thymocytes. 
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Figure 3.6. Comparison of standard migratory measurements between intravital and 
explanted preparations. 
X, Y and Z positional data as well as YPET intensity data gathered using Imaris analysis were 
used in combination with 2Ptrack.net (Miller laboratory and Johannes Textor) and GraphPad 
Prism to compare thymocyte behavior within the live and explanted thymic preparations. (A) 
Mean speed, (B) track straightness, (C) motility coefficient (D) mean square displacement (E) 
the correlation between mean YPET intensity and speed were evaluated. 
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Figure 3.6. Comparison of standard migratory measurements between intravital and 
explanted thymic preparations. 
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Figure 3.7. Intravital, in situ imaging allows for the visualization and quantification of 
thymic seeding events. 
ActinCFP reporter bone marrow is administered intravenously into B6.K mice after the post 
surgical addition of quantum dot 655. Within 15 minutes after transfer, bone marrow derived 
cells can be (A) visualized at various stages of extravasation (left), including rolling (middle) and 
rapid circulation in the blood vessels (right). These dynamics were tracked (B) in Imaris (left) 
and represented using 2Ptrack.net software (right). These dynamics can be quantified using 
Imaris and GraphPad (C) highlighting the motility circulating cells and tracks (left and middle 
left) as well as extravasating cells and tracks (middle right and right). 
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Figure 3.7. Intravital, in situ imaging allows for the visualization and quantification of 
thymic seeding events. 
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CHAPTER IV 
 
Self-pMHCII and TCR self-reactivity impact the peripheral homeostasis of mature CD4 T cells  
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Introduction 
T cell immunity is a tightly regulated process in which a naive pool of T cells capable of 
responding to pathogens must be maintained in the steady state. Pathogen specific T cells then 
undergo massive expansion during an immune response, followed by dramatic contraction to the 
steady state level while maintaining a small population of memory cells for future protection 
against said pathogens81. The mechanisms of steady state homeostasis of naive and memory T 
cells are being worked out, and it is widely thought that though naive and memory CD4 and CD8 
T cells are regulated by a unique synergy of mechanisms, they all rely to some degree on 
cytokine and self-pMHC derived signals158. The study of exactly how or if self-pMHCII impact 
CD4 T cell homeostasis has been mired with debate, with most of these studies relying on 
MHCII ablation to study the role of TCR:pMHC in steady state homeostasis76, 159, 160. 
 
Some of the controversy surrounding the role for self-pMHC in CD4 T cell homeostasis stems 
from differences in the systems utilized. In normal lymphoreplete hosts with complete immune 
systems, polyclonal CD4 cells undergo minimal proliferation. However when rendered 
lymphopenic, either chronically (Rag-/-) or acutely (sublethally irradiated), CD4 cells undergo 
proliferation and conversion into memory phenotype cells. It has been proposed that the source 
of homeostatic self-pMHCII signals differ depending on the lymphopenic environment, and 
some argue that lacking MHCII results in enough lymphopenia that interpretation of these results 
are confounded by space-induced proliferation, and do not solely reflect the role of pMHCII in 
naive CD4 T cell homeostatic proliferation63. Well regarded studies have suggested that since 
Rag-/- mice are chronically infected with commensal bacteria, and “self” proteins are 
predominately derived from this source during chronic lymphopenia, the homeostatic 
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proliferation observed is largely commensal organism driven. Under acutely lymphopenic 
conditions however, low affinity self-peptides predominately drive proliferation of naive CD4 T 
cells79, 82_ENREF_7. A closer look at the T cells that undergo homeostatic proliferation after 
being adoptively transferred into lymphopenic recipients shows that some of have acquired a 
CD44high memory phenotype. In this study, we have focused on the sublethally irradiated, 
acutely lymphopenic homeostatic system. 
 
Despite the ongoing debate, overwhelming evidence points to some role for self-peptides in 
maintaining the mature T cells pool, even suggesting that it is the same ligands that mediate 
intrathymic selection that are required for peripheral T cell homeostasis73, 75, 161. The fact the 
selected T cells have a small range of affinity for self-peptide as a result of the selection process 
has prompted the question of whether the self-reactivity of a given T cell impacts it peripheral 
homeostasis. The sensitivity of mature T cells for self-pMHC is established during thymic 
development; the strength of this spMHC:TCR interaction is represented by CD5 expression 
levels48, 52. The few studies that have began to investigate the role of self-reactivity in T cell 
homeostasis suggest that T cells with a high affinity for self-pMHC have a competitive 
advantage in homeostatic survival and proliferation83, 162.  
 
Results 
As discussed above, addition of exogenous gp250 positive selecting peptide to chronically 
lymphopenic B6.K Rag1-/- recipients of adoptively transferred ANDtg CD4 T cells significantly 
increased the survival of these transgenic T cells (Figure 1.5). This is in keeping with the notion 
that the same ligands mediating intrathymic positive selection also provide essential cues for the 
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homeostatic maintenance of naive CD4 T cells in the periphery. To our knowledge, this is the 
first explicit example of a bona fide selecting ligand impacting peripheral maintenance. We 
sought to further confirm that the naturally occurring positive selecting self-pMHCII, gp250/I-
Ek, supported homeostatic maintenance of ANDtg CD4 T cells by utilizing the gp250 deficient 
animals as recipients, compared to gp250+/+ B6.K recipients. During routine analysis of our 
newly generated polyclonal gp250 KO mice, we uncovered a significant reduction in polyclonal 
Vβ3 expressing CD4 T cells (Figure 4.1). Though the ANDtg CD4 T cell expresses a Vβ3 TCR, 
it is unlikely that one ligand is responsible for the selection of a majority of Vβ3 expressing 
polyclonal CD4 T cells. Indeed, the Vβ3 TCRs are known to be highly amenable to endogenous 
retroviral (mouse mammary tumor virus) super-antigen mediated deletion163. As such, we closely 
investigated the genomic heterogeneity of the gp250 KO mice; heterogeneity within the genome 
was revealed, though not at loci known for super-antigen mediated Vβ3 deletion164, 165. With the 
help of the Rheumatic Disease Core Center, we used speed congenics to further backcross the 
gp250 KO mice to B6 background resulting in heterogeneity confined solely to chromosome 9 
on which the LR11 gene, from which gp250 is derived, is located (Figure 4.2). The 
ANDtg/Rag1-/-/gp250-/- mice were re-derived by breeding ANDtg/Ragkk animals with these fully 
backcrossed gp250 KO mice, and evaluated for the production of Vβ3+Vα11+ ANDtg CD4 T 
cells. As opposed to the dramatic loss of ANDtg CD4 T cells initially observed (Figure 1.7), the 
new litters showed only modest reductions in ANDtg CD4 T cell development (Figure 4.3). 
Though work in our laboratory and others has indicated a high degree of specificity among the 
self-pMHC that can select a given TCR, it is not surprising to find that, though sufficient for 
positive selection, gp250 is not the sole ligand capable of mediating the intrathymic development 
of the ANDtg CD4 T cell.  Despite the revelation that gp250/I-Ek is not a necessary self-pMHCII 
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ligand responsible for the selection of ANDtg CD4 T cells, it has proven to be a sufficient and 
dominant selecting ligand and useful tool in the evaluation of endogenous, physiological self-
pMHCII characteristics and functions. 
 
Having identified one of only a few bona fide CD4 T cell positive selection systems, we sought 
to closely evaluate the contribution of gp250/I-Ek self-pMHCII to the maintenance and 
proliferation of naive CD4 T cells. Given that acutely lymphopenic, sublethally irradiated 
recipients are widely thought to support predominately self-pMHC mediated homeostatic 
proliferation79, we focused our attention on the role of selecting ligand gp250 in this setting. One 
week after adoptive transfer of ANDtg CD4 to cells into acutely irradiated B6.K or gp250 KO 
recipients, we observed no significant differences in the survival, as measured by recovery, or 
proliferation of the transferred ANDtg CD4 T cells (Figure 4.4). Given our recent discovery that 
gp250/I-Ek was a sufficient but not necessary selecting ligand for the ANDtg CD4 T cell, it is 
possible that unknown ANDtg selecting ligands are providing the necessary homeostatic cues in 
both the B6.K and gp250 KO recipients.  
 
We next investigated whether exogenously increasing the amount of the naturally occurring 
positive selecting ligand would impact the homeostatic characteristics of the ANDtg CD4 T cells 
in the acutely lymphopenic setting. We added gp250 peptide intraperitoneally one day before and 
after the adoptive transfer of ANDtg CD4 T cells into acutely lymphopenic B6.K recipients. 
After 7 days, we noticed no significant difference in total ANDtg CD4 T cell survival or division 
with the addition of exogenous gp250 peptide (Figure 4.5 A-C). However, upon closer 
inspection we identified a consistent pool of rapidly dividing ANDtg CD4 T cells upon addition 
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of exogenous gp250 peptide; without exogenous peptide, no rapidly dividing population existed. 
The ANDtg CD4 T cells that underwent rapid proliferation also exhibited a CD44high memory 
phenotype (Figure 4.5 D-F). Thus, it appears that increasing the amount of positive selecting 
ligand may prompt homeostatically proliferating CD4 T cells to divide more rapidly.  
 
Having a novel, naturally occurring CD4 T cell selection system in which to investigate the role 
of selecting ligands in peripheral T cell homeostasis is an incredible advancement, however as 
with other known selecting ligands we do not have an affinity measurement for the weak ANDtg 
CD4 TCR:gp250/I-Ek interaction. To further investigate the characteristics of self-pMHC that 
mediate homeostatic maintenance, we employed the LLO TCRtg system generated in our 
laboratory. Using this system, we can investigate how two T cells which recognize the same 
cognate antigen with equivalent affinities, yet differ in their reactivity to self-pMHC, are 
maintained in the periphery. As described in the introduction LLO56 TCRtg CD4 T cells express 
higher levels of CD5 than LLO118 TCRtg CD4 T cells (Figure 1.8), a finding we have 
interpreted to indicate that the LLO56 cells have an increased reactivity to self-pMHC than do 
LLO118 cells. One week after adoptive transfer of LLO TCRtg CD4 T cells into acutely 
irradiated B6 mice, we found that the CD5high LLO56 cells underwent increased proliferation 
when compared to the LLO118 TCRtg CD4 T cells. Despite this increased proliferative capacity, 
the LLO56 TCRtg CD4 T cells survive less well as indicated by the frequency and number of 
recovered cells (Figure 4.6). The same was true of a disparate TCRtg pair; both recognize 
hemoglobin (Hbd(64-76)/I-Ek) as their cognate antigen but differ in CD5 expression166, 167. After 
adoptive transfer into acutely lymphopenic hosts, we noted that the CD5high 2.102 TCR exhibited 
poorer survival but increased proliferation in comparison to the CD5low N3L2 TCRtg CD4 T 
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cells (Figure 4.7). These data would suggest that, though CD5high expression results in an 
increased proliferative capacity in response to homeostatic cues, presumably self-pMHC, these 
highly self reactive cells are not well maintained.  
 
We next investigated if exogenous addition of a pool of I-Ab binding self-peptides could increase 
the homeostatic proliferation of LLO118tg CD4 T cells, similarly to as was seen with the 
naturally occurring ANDtg CD4 T cell selecting self-pMHCII gp250/I-Ek. Though none of these 
ligands are confirmed LLO TCRtg positive selecting ligands, they are naturally occurring self-
peptides identified from activated B cells and macrophages168. One week after adoptive transfer 
and intraperitoneal administration of a 10 I-Ab self-peptide pool we observed no significant 
increase in the survival or proliferation of LLO118tg CD4 T cells (Figure 4.8). We sought to 
determine if altered peptide ligands (APLs), which bind LLO56 or LLO118 TCR but do not 
stimulate the T cell directly, can impact the homeostatic characteristics of the LLOtg CD4 T 
cells. Using a panel of LLO APLs previously identified in the laboratory we performed adoptive 
transfer assays as described above. We observed that the addition of antagonist peptides 
increased the amount of rapid proliferation that occurred over the 7 day period for both LLO56 
and LLO118. This effect was considerably more dramatic for the CD5low LLO118tg than the 
CDhigh LLO56tg CD4 T cell (Figure 4.9). This suggests that antagonist peptides can augment 
homeostatic proliferation, and that less self-reactive CD4 T cells are more susceptible to changes 
induced by these ligands. 
 
We were curious if CD5 was playing a direct role, either positive or negative, in the homeostasis 
of LLOtg CD4 T cells. Though often utilized simply as a surrogate for self-pMHC affinity, CD5 
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has also been attributed with the negative regulation of TCR signaling68, 71, 169. Indeed, work 
from our laboratory has shown that LLO TCRtg CD4 T cells lacking CD5 exhibit increased IL-2 
production and ERK phosphorylation when stimulated52. We utilized the LLO56 and LLO118 
CD5KO mice as donors in our acute lymphopenia homeostatic assay. With both LLO56tg and 
LLO118tg CD4 T cells, the absence of CD5 elevated their homeostatic proliferation and 
survival. No cells were covered from the negative control H-2DM KO recipients (Figure 4.10). 
These increases were most marked for the less self reactive LLO118tg CD4 T cells. This 
suggests that CD5 may function to dampen the steady state response to self-pMHC. However, 
given that LLO56tg CD4 T cells did not exhibit a vast increase in homeostatic proliferation and 
survival, there are likely compensatory mechanisms for maintaining the homeostatic expansion 
of highly self reactive TCRs at an appropriate level. 
 
Conclusion 
In this study we have shown that self-peptides and the degree of self-reactivity can impact the 
homeostatic proliferation of CD4 T cells. Specifically, the exogenous addition of the bona fide 
selecting ligand gp250/I-Ek to acutely lymphopenic hosts can increase the prevalence of rapidly 
divided ANDtg CD4 T cells. Investigating how the TCR affinity for self-pMHCII impacted 
peripheral homeostasis employed two TCRtg systems, LLO and Hbd.  In each system it was 
revealed that the less self-reactive CD5high TCRtg pair, LLO56 and 2.102 respectively, 
underwent increased homeostatic proliferation. Despite the increased proliferative capacity of the 
CD5high CD4 cells they survived less well compared to their CD5low counterparts. Antagonist 
peptides were able to induce a rapid proliferation of LLO TCRtg CD4 T cells similar to that of 
gp250 and the ANDtg CD4 T cell. This effect was more pronounced when investigating 
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LLO118tg CD4 T cell antagonists, suggesting that CD5low cells with reduced affinity for self-
pMHCII are more responsive to changes in the peptide landscape. 
 
Discussion 
We have investigated the interplay between self-pMHC, strength of self-reactivity and naive 
CD4 T cell homeostasis. Initially, we had hypothesized that if positive selecting self-pMHC were 
in fact required for the homeostatic proliferation and maintenance of naive CD4 T cells, then 
eliminating the dominant selecting ligand for ANDtg CD4 T cells in the gp250KO mice would 
eliminate the proliferation and survival of these cells. However, given that gp250/I-Ek is not the 
sole ligand capable of mediating ANDtg CD4 T cell selection, it is not surprising that elimination 
of this ligand alone did not preclude the proliferation and survival of the ANDtg T cells. This 
does not negate the importance of (selecting) self-peptides in the homeostatic maintenance of 
CD4 T cells. Rather, it suggests that other self-ligands, besides the positive selecting ones, may 
compensate for the homeostatic cues provided by gp250/I-Ek.  
 
Because we do not have an affinity measurement for the weak interaction of ANDtg CD4 TCR 
with the positive selecting gp250/I-Ek ligand, we sought to investigate how the strength of self-
reactivity impacted homeostasis. In two separate TCRtg systems, we found that increased self-
reactivity resulted in increased homeostatic proliferation. Despite the increased presence of 
dividing cells, these highly self-reactive TCR were less prone to survival compared to their 
TCRtg counterparts exhibiting lower self-reactivity. It has been proposed in other studies that 
homeostatic proliferation and survival are not necessarily regulated by the same cues. Indeed, it 
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appears that the while strong self-reactivity may augment proliferation, this trait does not lend 
itself to increased survival. 
  
The studies wherein exogenous peptide was added before and after adoptive transfer of TCRtg 
cells suggest that the abundance self-peptide can impact the homeostatic characteristics of a 
naive CD4 T cell. Specifically, they increase the frequency of rapid “burst-like” divisions. As 
has been proposed, we observe that these cells have a memory phenotype, expressing high levels 
of CD44 compared to the slowly dividing transferred cells. The purpose of these cells is of 
interest; unlike traditional memory CD4 T cells, these CD44high cells have not experienced 
cognate antigen. Extensive “burst-like” proliferation was also observed when adding antagonist 
peptide to the LLO systems. Though not bona fide positive selecting ligands, antagonist peptides 
have long been used to mimic positive selection due to their inability to classically activate T 
cells while still interacting with the TCR. Interestingly, the antagonists had a greater effect on the 
homeostatic proliferation of the CD5low LLO118tg CD4 T cells compared to LLO56tg. This 
suggests that peptide abundance may play a larger role in the homeostasis of T cells that are less 
self-reactive, as measured by CD5 expression levels. 
 
The exact functional role of CD5 is debated. It is an accepted readout of a TCR’s affinity for 
self-peptides, and this has proven a useful tool in these studies. However, we were interested in 
whether CD5 played a functional role in regulated T cell characteristics. In regards to 
homeostasis, it appears that CD5 does in fact reduce the homeostatic proliferation and survival of 
naive CD4 T cells, as CD5KO LLOtg cells showed increases in these parameters compared to 
the CD5 sufficient LLOtg CD4 T cells. We had anticipated that any direct effect of CD5 would 
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be exacerbated in the CD5high LLO56tg CD4 T cells compared to CD5low LLO118. However, we 
observed the opposite. We suggest that highly self-reactive T cells are endowed with more 
abundant compensatory negative regulatory components than cells that are less prone to self-
reactivity. As such, removing CD5 from the equation would augment proliferation to a greater 
capacity in the less self-reactive CD4 compartment which posses less stringent negative 
regulatory elements.  
 
There appears to be a complicated interplay between the landscape of self-ligands, the abundance 
of these ligands and a T cell’s inherent affinity for self-peptides. The experiments herein did not 
address the important role of cytokines and competition for homeostatic cues that will also 
influence the steady state maintenance of a T cell pool. Taken together these data suggest that 
self-peptides and a TCR’s affinity for such ligands impact their peripheral maintenance in a 
complex manner. 
 
Materials and methods 
Mice 
The gp250 deficient mice 92 were bred to the B6.K (H-2k restricted) line (JAX 001148). The 
mice were extensively backcrossed to B6.K, and were monitored by the analysis of microsatellite 
markers at the Rheumatic Disease Core Center, Washington University School of Medicine (St. 
Louis, MO) as described above. The MCC–I-Ek specific AND TCRtg 89, 170, B6.K (H-2k), 
C57BL/6 (B6, H-2b) (JAX 000664) and B6.Rag1−/− (JAX 002096) mice were purchased from 
The Jackson Laboratory. The AND TCRtg line was bred onto Rag1−/− background: 
AND.Rag1−/−H-2k. AND.Rag1−/−H-2k mice were bred to fully backcrossed gp250 KO mice to 
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generate ANDtg/Rag1-/-/gp250-/- mice.  The LLO TCRtg mice were generated in our laboratory 
as previously described. The LLO56 and LLO118 TCRtg CD4 T cells recognize the same 
immunodominant epitope listeriolysin O (190-205) from Listeria monocytogenes (LLO190-205/I-
Ab) 2, 24. CD5-/- mice were obtained as part of the NIAID Exchange Program from the transgenic 
mouse repository maintained by Taconic. These mice were bred to the LLO TCRtg mice to 
generate LLO56 CD5KO and LLO118 CD5 KO mice. The n3.L2/B6.K and 2.102/B6.K mice 
were previously generated in our laboratory and were crossed to the Rag1−/- line166, 
167_ENREF_20. H-2DM-/- β2m-/- mice were provided by Jenny Ting’s laboratory; these mice 
were backcrossed to B6, and the F1 progeny intercrossed to restore the WT β2m alleles, thus 
generating the H-2DM KO mice used in this study. All mice were between the ages of 4-12 
weeks and were bred and housed in specific pathogen–free conditions of the animal facility at 
the Washington University Medical Center. The use of all laboratory animals was approved and 
performed in accordance with the Washington University Division of Comparative Medicine 
guidelines. 
 
Adoptive transfer assays 
For acute lymphopenia homeostatic assays, recipient mice were sublethally irradiated with a 
dose of 600 rads on day -2. On day 0, spleen and lymph node are harvested from donor mice, 
made into a single cell suspension and counted. CD4 T cells were isolated by magnetic bead 
positive selection (Miltenyi). CD4 purified cells are CFSE labeled, and 1x106-2x106 are 
intravenously transferred to recipient mice by tail vein injection. Spleen and axial, brachial and 
inguinal lymph nodes from individual mice are harvested on day 7. Flow cytometric analysis of 
donor cell recovery and division follows. “Rapid” divisions are representative of the final 2-3 
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peaks of CFSE dilution, while “slow” division includes the first 2-3 peaks of CFSE dilution. 
Data in this study show lymph node populations. In assays where exogenous peptides are added 
to the homeostatic systems, 100µg of peptide is administered intraperitoneally on day -1 and day 
+1; non-peptide controls receive and equal volume of PBS intraperitoneally. Statistical analysis 
is performed using GraphPad Prism 6 (GraphPad Software). 
 
Peptides 
All peptides were synthesized, purified, and analyzed in house as previously described using a 
Symphony automated solid-phase peptide synthesizer via Fmoc chemistry and high performance 
liquid chromatography86. gp250 peptide is described above. 
I-Ab bindng self-peptides 
FcgR(231-245) EVGEYRQPSGGSVPV 
DEC205(562-579) DPDSRGEYSWAVAQGVKQ 
Int B1(778-794) GENPIYKSAVTTVVNPK 
CD98(207-223) GQNAWFLPAQADIVATK 
CD22(25-39) DWTVDHPQTLFAWEG 
IgM(376-391) EKYVTSAPMPEPGAPG 
LDLR(486-501) RNIYWTDSVPGSVSVA 
I-Ab(50-64) RPDAEYWNSQPEILE 
Actin(163-177) VPIYEGYALPHAILR 
GAPDH(227-242) TGMAFRVPTPNVSVVD 
 
LLO altered peptide ligands 
LLO(190-205)K197 NEKYAQAKPNVSAKID 
LLO(190-205)F197 NEKYAQAFPNVSAKID 
LLO(190-205)G194 NEKYGQAYPNVSAKID 
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Flow cytometry 
 
The following antibodies were used for flow cytometry: Live/Dead UV-Violet (Invitrogen), anti-
CD4 (RM4-4, RM4-5 and GK1.5), anti-CD44 (IM7) anti-CD5 (53-7.3), anti CD45.1 (A20), anti-
Thy1.1 (OX-7), anti-Vβ3 (8F10), and anti-Vα11 (RR8-1) from eBioscience or Biolegend as well 
as CFSE (Invitrogen). 
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Figure 4.1. gp250 deficient mice have polyclonal Vβ3 TCR deletion. Flow cytometric analysis 
of polyclonal gp250 KO mice exhibited reduced Vβ3 TCR expression on CD4 SP thymocytes 
(A) as well as mature CD4 cells in the lymph node and spleen (B) compared to B6.K (WT) cells. 
Data are representative of at least 3 experiments and depict mean ± SEM. 
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Figure 4.1. gp250 deficient mice have polyclonal Vβ3 TCR deletion. 
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Figure 4.2. Speed congenic backcrossing of gp250 deficient mice. Chromosomal map of 
gp250 KO mouse compared to B6 before (A) and after (B) backcrossing via speed congenics. 
Regions of heterogeneity are indicated in green; chromosomal locations of known Vβ3 TCR 
deleting endogenous retroviruses are indicated in red; the orange box indicates the approximate 
chromosomal location of LR11, also named SorLA, at 41.983-41.985 cM. 
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Figure 4.2. Speed congenic backcrossing of gp250 deficient mice. 
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Figure 4.3. ANDtg CD4 T cells continue to be selected in the absence of gp250. Flow 
cytometric analysis of (A) thymus and (B) spleen from the newly backcrossed 
ANDtg/gp250KO/Ragk/k mice shows no difference in the production of Vβ3+ Vα11+ ANDtg 
CD4 T cells between gp250 deficient (KO) and sufficient (WT) mice. Data are representative of 
at least 3 experiments. 
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Figure 4.3. ANDtg CD4 T cells continue to be selected in the absence of gp250. 
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Figure 4.4. ANDtg CD4 T cells maintain their homeostatic characteristics in the absence of 
gp250/I-Ek positive selecting ligand. (A) CFSE dilution profile of ANDtg CD4 T cells 
adoptively transferred into acutely lymphopenic gp250 deficient (KO) and B6.K (WT) 
recipients. Quantification of (B) absolute number recovered (C) percent of transferred cells 
recovered and (D) percent divided. 
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Figure 4.4. ANDtg CD4 T cells maintain their homeostatic characteristics in the absence of 
gp250/I-Ek positive selecting ligand. 
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Figure 4.5. Addition of exogenous gp250 positive selecting ligand promotes the rapid 
division of ANDtg CD4 T cells. Quantification of (A) absolute number recovered (B) percent of 
transferred cells recovered and (C) percent of cells divided after intraperitoneal injection of 
gp250 peptide before and after adoptive transfer of ANDtg CD4 T cells into acutely 
lymphopenic B6.K mice that did (+gp250) and did not (no peptide) receive exogenous gp250 
peptide. (D) CFSE dilution profile of ANDtg CD4 T cells. “Rapid” division indicates 7 or more 
divisions, while “slow” division represents 2-3 rounds of CFSE dilution. (E) Quantification of 
the frequency of rapid and slowly dividing cells among total ANDtg CD4 T cells undergoing 
division, with or without exogenous peptide. (F) CD44 expression differences between rapidly 
and slowly dividing ANDtg CD4 T cells in the presence of exogenous gp250 peptide. 
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Figure 4.5. Addition of exogenous gp250 positive selecting ligand promotes the rapid 
division of ANDtg CD4 T cells.  
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Figure 4.6. CD5high LLO56 TCRtg cells exhibit increased proliferation and decreased 
survival compared to CD5low LLO118 TCRtg counterpart. (A) CFSE dilution profile of 
donor CD5high LLO56 and CD5low LLO118 TCRtg CD4 T cells one week after adoptive transfer 
into acutely (600 rads) lymphopenic B6 hosts. Quantification of (B) absolute number (C) 
recovery rate and (D) frequency of division among LLO56 and LLO118 donor CD4 T cells.  
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Figure 4.6. CD5high LLO56 TCRtg cells exhibit increased proliferation and decreased 
survival compared to CD5low LLO118 TCRtg counterpart. 
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Figure 4.7. CD5high 2.102 TCRtg cells exhibit increased proliferation and decreased 
survival compared to CD5low n3L2 TCRtg counterpart. (A) Flow cytometric analysis of CD5 
expression levels between Hbd specific CD4tg T cells 2.102 and n3L2. Quantification of (B) 
absolute number (C) recovery rate and (D) frequency of division among 2.102 and n3L2 donor 
CD4 T cells. 
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Figure 4.7. CD5high 2.102 TCRtg cells exhibit increased proliferation and decreased 
survival compared to CD5low n3L2 TCRtg counterpart. 
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Figure 4.8. Addition of exogenous I-Ab self-peptide pool does not significantly the 
homeostatic characteristics of LLO118 TCRtg CD4 T cells. (A) CFSE dilution profile one 
week after intraperitoneal injection of an I-Ab self-peptide pool before and after adoptive transfer 
of LLO118tg CD4 T cells into acutely lymphopenic B6 mice that did (118 + peptide) and did not 
(56 or 118) receive exogenous I-Ab self-peptide. Quantification of (B) absolute number (C) 
recovery rate and (D) frequency of division among LLO56tg, LLO118tg and LLO118tg with 
exogenous peptide. 
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Figure 4.8. Addition of exogenous I-Ab self-peptide pool does not significantly the 
homeostatic characteristics of LLO118 TCRtg CD4 T cells. 
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Figure 4.9. LLO TCRtg antagonist peptides promote the rapid proliferation of LLO56tg 
and LLO118tg CD4 T cells. (A) Panel of LLO altered peptide ligands with differing TCR 
binding characteristics. Red highlights the antagonist peptides for LLO118tg (F197) and 
LLO56tg (G194 and K197) CD4 T cells. CFSE dilution profiles of (B) LLO118tg and (C) 
LLO56tg one week after intraperitoneal injection of antagonist peptides before and after adoptive 
transfer of LLOtg CD4 T cells into acutely lymphopenic B6 mice that did and did not (LLO56 or 
LLO118) receive exogenous antagonist peptide. (D) Quantification of the rapidly divided LLOtg 
CD4 T cells in the presence of absence of exogenous antagonist peptide. 
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Figure 4.9. LLO TCRtg antagonist peptides promote the rapid proliferation of LLO56tg 
and LLO118tg CD4 T cells.  
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Figure 4.10. CD5 deficient LLOtg CD4 T cells exhibit increased homeostatic 
characteristics. (A) CD5 expression levels of CD5KO and CD5 sufficient LLOtg CD4 T cells. 
(B) CFSE dilution profile of donor CD5 KO LLO56tg (left) and CD5 KO LLO118tg (right) CD4 
T cells one week after adoptive transfer into acutely (600 rads) lymphopenic B6 hosts. 
Quantification of (C) absolute number (D) recovery rate and (E) frequency of division among 
CD5KO LLO56 and LLO118 donor CD4 T cells. Black indicated CD5 sufficient LLOtg CD4 T 
cells, while red indicates CD5 KO LLOtg T cells as donors into acutely lymphopenic B6 
recipients. Blue indicates homeostasis negative control H-2 DM deficient recipients of CD5 
sufficient LLOtg donor CD4 cells. 
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Figure 4.10. CD5 deficient LLOtg CD4 T cells exhibit increased homeostatic 
characteristics. 
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CHAPTER V 
 
Discussion and future directions 
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The studies performed in this dissertation have made novel advances in the fields of CD4 T cell 
development, including live, in situ visualization of intrathymic dynamics and characterizations 
of a physiological selecting self-pMHCII landscape, and homeostatic maintenance of peripheral 
CD4 T cells. We can further take advantage of the systems described in the following ways. 
 
Future investigation of the endogenous self-pMHCII landscape 
We have successfully surveyed the expression of a bona fide positive selecting ligand in the 
thymus and periphery. We suspect that post-translational modification (PTMs) may impact this 
landscape. In future work, we will perform western blot analysis to elucidate if PTMs, such as 
glycosylation, phosphorylation and ubiquitination, are causing the observed discrepancy between 
mRNA expression and functional expression of gp250/I-Ek complexes. Given that immune 
response factors are known the impact the PTM of pMHC and this has been suggested to play a 
role in autoimmunity110, it will be of particular interest to look at PTMs in steady state and 
activated APCs. Aside from Listeria infections, we investigate if parasitic or viral pathogens alter 
the self-pMHCII landscape. Many environmental factors have been suggested to trigger 
autoimmunity171, and future studies may investigate if changes to the self-pMHC landscape and 
subsequent alterations to the T cell pool may be a potential mechanism of such triggers. 
Advances in sequencing technology and reductions in cost allow to potential to investigate the 
TCR repertoire in response to self-pMHC landscape alterations. 
 
Additionally, having unequivocally shown, for what we believe to be the first time, that a 
physiological self-pMHCII can be presented on both positive selecting and tolerance induce 
thymic APCs, we are in a position to further investigate the role of public, widely expressed, and 
private, uniquely expressed, ligands in T cell development and peripheral maintenance. We 
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know that ANDtg CD4 T cells can be selected by more than one self-pMHCII. Though 
herculean, it may be of interested to identify an additional self-ligand for comparison to the 
public gp250/I-Ek ligand. 
 
Intravital characterization of thymus seeding events and intrathymic selection 
One of the biggest advantages of our novel intravital, in situ thymus imaging preparation is the 
ability to visualize the entry of T cell progenitors into thymus from the blood. Future studies will 
replicate these initial experiments wherein whole bone marrow cells were intravenously 
administered and observed entering the thymus. Because mature T cells are not known to 
recirculate through the thymus to any significant degree, we suspect that the thymus is a stringent 
gate keeper and the bone marrow cells we observe entering the thymus are common lymphoid 
progenitors. However, we can FACS sort common lymphoid progenitor prior to administration 
for two-photon analysis to purify the population of thymic seeding cells. We will also investigate 
the role of soluble molecules suggested to regulate thymus entry and intrathymic development in 
this system. 
 
Additionally, we can generate a reporter system to in which we can observe a bona fide positive 
selection event. Intrathymic administration of exogenous gp250 peptide was previously shown in 
our laboratory to enhance the selection of ANDtg CD4 T cells. Thus, we have the ability to 
initiate a positive selection event by adding exogenous gp250 peptide to our transgenic CD4 T 
cell system. We propose to generate reporter mice in which the components of the 
ANDtg:gp250/I-Ek positive selection system can be identified, and use these reagents to 
determine the kinetics of a positive selecting event. Combining our ANDtg system with the 
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B6.CD69YPET reporter mice described herein, we can start to investigate the early events 
involved in positive selection using tow photon microscopy28, 47. By including carefully selected 
reporters for the thymic APCs into these imaging assays the cellular interplay between thymic 
APCs and the ANDtg thymocytes in the presence of exogenous gp250/I-Ek can be evaluated. We 
will thus be able to analyze the migratory behavior and cellular interactions of a known CD4 
TCR with selecting thymic APCs. 
 
Finally, we will closely investigate how temperature is impacting both the intravital and explant 
imaging preparations. As has been described elsewhere, even small changes in temperature can 
impact cellular motility124. We will perform the imaging preparations as described herein, while 
carefully controlling the temperature of the automated temperature regulation unit and perfusion 
media. We will also monitor the animal’s core body temperature in relation to the mechanical 
temperature to confirm that the heating elements are accurately maintaining the animal’s internal 
body heat.  
 
Clarification of the interplay between homeostatic cues 
Differences between the experimental systems used to study naive T cell homeostasis have made 
it hard to reconcile the work done across many groups, and indeed our studies suggest that the 
interplay between self-reactivity, (selecting) self-pMHCII peripheral landscape and homeostasis 
requires more investigation. The role of lymphopenia is a major source of discrepancy. Naive 
TCRtg and polyclonal cells have been shown to undergo increased proliferation and CD44high 
conversion upon adoptive transfer into chronically lymphopenic compared to acutely 
lymphopenic recipients79. The source of pMHC is also shown to differ in those setting, with 
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acute radiation induces lymphopenia being self-pMHC mediate, as no foreign antigens were 
involved. However in an MHCII monoclonal antibody mediated depletion of self-pMHCII 
interaction, BrdU remained to be incorporated in a population of CD44high cells, indicating a self-
pMHCII independent meditated proliferation172. They show a role for cytokine-driven 
homeostatic proliferation in supplying the memory phenotype pool; cytokine involvement in 
CD4 T cell homeostasis is an important component we will investigate in the future. Our 
experiments adding self and antagonist self-peptide mimics to acute homeostasis transfer 
systems suggest that self-pMHCII do play a role in homeostatic proliferation. However the many 
differences in the systems make these difficult to compare, specifically the mode of lymphopenia 
or pMHC inhibition, the transfer versus endogenous source of CD44high cells and the tracking of 
division be CFSE dilution or BrdU incorporation. 
 
Having identified these antigen inexperienced CD44high memory phenotype cells, questions 
regarding their function have naturally arisen.  Naive animals have been estimated to have 10-
20% CD44high T cells in the stead state173. Induction of acute, radiation-induced lymphopenia 
increases the frequency, however few of these memory phenotype cells were shown to make 
TNFα or IFNγ79. Some have speculated that they supply a pool of cross-reactive memory cells or 
play some kind of role when antigen experienced memory cells are not available67, 174. In the 
future, our laboratory can utilize the ANDtg system to investigate the role of CD44high memory 
phenotype ANDtg CD4 T cells in response to cognate MCC antigen. The identification of gp250 
as the a bona fide selecting ligand will allow for investigation of how selecting self-pMHCII 
impacts the response to foreign antigens. 
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We have made a connection between the strength of self-reactivity, self-pMHCII, and rapid 
proliferation and CD44high memory phenotype conversion. While other laboratories have noted a 
concurrent increase in both homeostatic proliferation and survival as measured by recovery, for 
CD5high self-reactive T cells83, 162, we observed in two separate systems that increased 
homeostatic proliferation was in opposition to survival. We push this observation further by 
showing that the CD5low CD4 T cells are more receptive to increases in self-MHCII. In the 
future, we will investigate whether the antagonist LLO peptide utilized herein are capable of 
selecting LLOtg CD4 T cells in in vitro fetal thymic organ culture, as some antagonists have 
been shown to do95. This will confirm that these antagonists are effective selecting self-peptide 
mimics. We will also attempt to establish where within the narrow affinity window of allowable 
self-reactivity the mature ANDtg CD4 T cells lie, to further investigate the interplay between 
self-reactivity and peripheral self-pMHCII, using a bona fide physiological self-pMHCII. 
Comparing the CD5 levels of polyclonal B6.K and ANDtg CD4 T cells will be an initial step. 
We can then utilize the previously identified I-Ek self-pMHC to see if any naturally occurring 
self-ligands impact polyclonal and ANDtg CD4 T cell homeostasis in the periphery. These same 
I-Ek self-peptides can be used in assays with the Hbd TCRtg system. Though it is known that 
these peptides do not positively select the TCRs in question, these assays will show of if any 
non-selecting self-peptides augment the homeostatic traits of the CD4 T cells. It should be noted 
that peripheral CD5 expression levels have been reported to fluctuate in the periphery175. Given 
that our laboratory has shown that CD5 itself can augment homeostatic proliferation within these 
experiments, as well as antigen responses in published data52, it will be important to further 
elucidate what impact CD5 has on peripheral T cells outside of reporting self-reactivity. 
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